<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000938.pub2" GROUP_ID="PREG" ID="323499081020085543" MERGED_FROM="" MODIFIED="2016-05-23 11:06:45 +0100" MODIFIED_BY="Frances Kellie" NOTES="&lt;p&gt;Difficult or impossible to recruit very large numbers to show a difference in brachial plexus injury.....&lt;/p&gt;" NOTES_MODIFIED="2016-05-23 11:02:55 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0185" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2016-05-23 11:06:37 +0100" MODIFIED_BY="Frances Kellie">
<TITLE MODIFIED="2016-02-29 12:37:16 +0000" MODIFIED_BY="[Empty name]">Induction of labour at or near term for suspected fetal macrosomia</TITLE>
<CONTACT MODIFIED="2016-05-23 11:06:37 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="4DE1376B82E26AA200991D566120CF1D" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jim</FIRST_NAME><MIDDLE_INITIALS>G</MIDDLE_INITIALS><LAST_NAME>Thornton</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>jim.thornton@nottingham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Division of Child Health, Obstetrics and Gynaecology, School of Medicine</DEPARTMENT><ORGANISATION>University of Nottingham</ORGANISATION><ADDRESS_1>Nottingham City Hospital NHS Trust</ADDRESS_1><ADDRESS_2>Hucknall Road</ADDRESS_2><CITY>Nottingham</CITY><ZIP>NG5 1PB</ZIP><REGION>Nottinghamshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 115 8231889</PHONE_1><FAX_1>+44 115 8231908</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-05-23 11:06:37 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="5699" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Michel</FIRST_NAME><LAST_NAME>Boulvain</LAST_NAME><POSITION>Médecin adjoint agrégé</POSITION><EMAIL_1>michel.boulvain@hcuge.ch</EMAIL_1><ADDRESS><DEPARTMENT>Département de Gynécologie et d'Obstétrique, Unité de Développement en Obstétrique</DEPARTMENT><ORGANISATION>Maternité Hôpitaux Universitaires de Genève</ORGANISATION><ADDRESS_1>Boulevard de la Cluse, 32</ADDRESS_1><CITY>Genève 14</CITY><ZIP>CH-1211</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+ 41 22 3824317</PHONE_1><FAX_1>+41 22 3824424</FAX_1><FAX_2>+41 22 3824165</FAX_2></ADDRESS></PERSON><PERSON ID="5761" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Olivier</FIRST_NAME><LAST_NAME>Irion</LAST_NAME><POSITION>Professor/Chair Obstetrics</POSITION><EMAIL_1>olivier.irion@hcuge.ch</EMAIL_1><URL>http://matweb.hcuge.ch/matweb/</URL><ADDRESS><DEPARTMENT>Département de Gynécologie et d'Obstétrique, Unité de Développement en Obstétrique</DEPARTMENT><ORGANISATION>Maternité Hôpitaux Universitaires de Genève</ORGANISATION><ADDRESS_1>Boulevard de la Cluse, 32</ADDRESS_1><CITY>Genève 14</CITY><ZIP>CH-1211</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+41 22 3824398</PHONE_1><PHONE_2>+41 22 3824203</PHONE_2><FAX_1>+41 22 3824424</FAX_1></ADDRESS></PERSON><PERSON ID="70FC7AD782E26AA201D1E765998F939C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Therese</FIRST_NAME><LAST_NAME>Dowswell</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>t.dowswell@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 7959575</PHONE_1><FAX_1>+44 151 7959598</FAX_1></ADDRESS></PERSON><PERSON ID="4DE1376B82E26AA200991D566120CF1D" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jim</FIRST_NAME><MIDDLE_INITIALS>G</MIDDLE_INITIALS><LAST_NAME>Thornton</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>jim.thornton@nottingham.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Division of Child Health, Obstetrics and Gynaecology, School of Medicine</DEPARTMENT><ORGANISATION>University of Nottingham</ORGANISATION><ADDRESS_1>Nottingham City Hospital NHS Trust</ADDRESS_1><ADDRESS_2>Hucknall Road</ADDRESS_2><CITY>Nottingham</CITY><ZIP>NG5 1PB</ZIP><REGION>Nottinghamshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 115 8231889</PHONE_1><FAX_1>+44 115 8231908</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-05-23 10:59:45 +0100" MODIFIED_BY="Frances Kellie">
<UP_TO_DATE>
<DATE DAY="31" MONTH="1" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="1" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="1" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="5" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-05-23 11:02:55 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-05-23 11:02:55 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="5" YEAR="2016"/>
<DESCRIPTION>
<P>Edited the plain language summary to include links to visual summaries (infographics) for this review. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-05-23 11:02:07 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-05-23 11:02:07 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="1" YEAR="2016"/>
<DESCRIPTION>
<P>Search updated. We have included one new trial and this updated review is now comprised of four studies (involving 1190 women).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2016-05-23 11:02:06 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="1" YEAR="2016"/>
<DESCRIPTION>
<P>A large high-quality trial has now been included (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>). Although no brachial plexus injuries occurred, the inclusion of other data from that trial means that the review now shows a reduction in birth fractures and shoulder dystocia and suggests that there is no overall increase in caesarean section.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-11-19 14:35:24 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>Search updated. No new reports identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-07-26 08:56:12 +0100" MODIFIED_BY="Sonja L  Henderson">
<DATE DAY="24" MONTH="7" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. No new reports identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-24 22:03:22 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="2" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-02-17 14:22:40 +0000" MODIFIED_BY="Sonja Henderson">
<DATE DAY="30" MONTH="9" YEAR="2007"/>
<DESCRIPTION>
<P>Search updated. A previously identified ongoing study has been completed (LIBBY 1998) and we have included the results in this update. The review's conclusions have not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-02-17 14:22:36 +0000" MODIFIED_BY="Sonja Henderson">
<DATE DAY="31" MONTH="7" YEAR="2004"/>
<DESCRIPTION>
<P>New search undertaken, as a result of which we have identified two new ongoing studies. We have also added a Synopsis.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-11-23 10:20:25 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Geneva</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2015-11-23 10:20:25 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-11-23 10:20:25 +0000" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>NIHR Cochrane Programme Grant Project: 13/89/05 &#8211; Pregnancy and childbirth systematic reviews to support clinical guidelines</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-05-23 11:01:50 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-05-23 11:01:50 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-03-09 10:29:22 +0000" MODIFIED_BY="[Empty name]">Induction of labour at or near the end of pregnancy for babies suspected of being very large (macrosomia)</TITLE>
<SUMMARY_BODY MODIFIED="2016-05-23 11:01:50 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>What is the issue?</B>
</P>
<P>Babies who are very large (or macrosomic, weighing over 4000 g when born) can have difficult and occasionally traumatic births. One suggestion to try to reduce this trauma has been to induce labour early, before the baby grows too big. The estimation of the baby's weight is difficult before birth and not very accurate. Clinical estimations are based on feeling the uterus and measuring the height of the fundus of the uterus. Both are subject to considerable variation. Ultrasound scanning is also not accurate, so suspected large babies may not be confirmed at delivery. This may worry parents.</P>
<P>
<B>Why is this important?</B>
</P>
<P>If undertaken too early, induction of labour can lead to babies being born prematurely and with immature organs.</P>
<P>
<B>What evidence did we find?</B>
</P>
<P>We found four trials that assessed induction of labour at 37 to 40 weeks for women when it was suspected that their baby was large. A total of 1190 pregnant, non-diabetic women were involved. We searched for evidence on 31 October 2015. The studies were of moderate or good quality although it was not possible to blind the women and staff providing care to which group women had been assigned. This may have introduced bias.</P>
<P>
<B>What does this mean?</B>
</P>
<P>The number of births where the baby's shoulder became stuck (shoulder dystocia) or a bone was fractured (usually the clavicle, which heals well without consequences) were reduced in the induction of labour group. The evidence was assessed as moderate quality for shoulder dystocia and high quality for fracture. No clear differences between groups were reported for damage to the network of nerves that send signals from the spine to the shoulder, arm and hand (brachial plexus injury) of the baby (low-quality evidence due to very few events occurring) or signs of not enough oxygen during birth. A policy of labour induction reduced the average birthweight of babies by 178 g. The trials did not show any differences in the number of women who had caesarean sections or instrumental births. There is limited evidence that more women in the induction of labour group had severe damage to the perineum. We conclude that there appear to be benefits, but there may also be some disadvantages of induction of labour shortly before term. The option of having an induction should be discussed with parents when their baby is suspected to be extra large.</P>
<P>Although some parents and doctors may feel the existing evidence is sufficient to justify inducing labour, others may disagree. Further high-quality studies are needed in order to find out what is the best time to induce labour towards the end of pregnancy, and how to improve the accuracy in diagnosing macrosomia.</P>
<P>A visual summary of some of the results from this review can be found here <A HREF="http://pregnancy.cochrane.org/sites/pregnancy.cochrane.org/files/uploads/induction-for-macrosomia%20%28screen%29.pdf">(screen view version)</A> and <A HREF="http://pregnancy.cochrane.org/sites/pregnancy.cochrane.org/files/uploads/induction%20for%20macrosomia%20%28printable%29.pdf">(printable version here)</A>.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-03-21 11:37:55 +0000" MODIFIED_BY="Heather Maxwell">
<ABS_BACKGROUND MODIFIED="2016-03-21 11:37:21 +0000" MODIFIED_BY="Heather Maxwell">
<P>Women with a suspected large-for-dates fetus or a fetus with suspected macrosomia (birthweight greater than 4000 g) are at risk of operative birth or caesarean section. The baby is also at increased risk of shoulder dystocia and trauma, in particular fractures and brachial plexus injury. Induction of labour may reduce these risks by decreasing the birthweight, but may also lead to longer labours and an increased risk of caesarean section.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-02-29 12:38:12 +0000" MODIFIED_BY="[Empty name]">
<P>To assess the effects of a policy of labour induction at or shortly before term (37 to 40 weeks) for suspected fetal macrosomia on the way of giving birth and maternal or perinatal morbidity.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-03-08 14:46:43 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 January 2016), contacted trial authors and searched reference lists of retrieved studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-08-05 09:34:10 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised trials of induction of labour for suspected fetal macrosomia.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-02-29 12:39:42 +0000" MODIFIED_BY="[Empty name]">
<P>Review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. We contacted study authors for additional information. For key outcomes the quality of the evidence was assessed using the GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-03-21 11:37:48 +0000" MODIFIED_BY="Heather Maxwell">
<P>We included four trials, involving 1190 women. It was not possible to blind women and staff to the intervention, but for other 'Risk of bias' domains these studies were assessed as being at low or unclear risk of bias.</P>
<P>Compared to expectant management, there was no clear effect of induction of labour for suspected macrosomia on the risk of <B>caesarean section</B> (risk ratio (RR) 0.91, 95% confidence interval (CI) 0.76 to 1.09; 1190 women; four trials, <I>moderate-quality evidence</I>) or <B>instrumental delivery</B> (RR 0.86, 95% CI 0.65 to 1.13; 1190 women; four trials, <I>low-quality evidence</I>). <B>Shoulder dystocia</B> (RR 0.60, 95% CI 0.37 to 0.98; 1190 women; four trials, <I>moderate-quality evidence</I>), and <B>fracture (any)</B> (RR 0.20, 95% CI 0.05 to 0.79; 1190 women; four studies, <I>high-quality evidence</I>) were reduced in the induction of labour group. There were no clear differences between groups for <B>brachial plexus injury</B> (two events were reported in the control group in one trial, <I>low-quality evidence</I>). There was no strong evidence of any difference between groups for measures of neonatal asphyxia; <B>low five-minute infant Apgar scores (less than seven)</B> or <B>low arterial cord blood pH </B>(RR 1.51, 95% CI 0.25 to 9.02; 858 infants; two trials, <I>low-quality evidence</I>; and, RR 1.01, 95% CI 0.46 to 2.22; 818 infants; one trial, <I>moderate-quality evidence</I>, respectively).</P>
<P>
<B>Mean birthweight</B> was lower in the induction group, but there was considerable heterogeneity between studies for this outcome (mean difference (MD) -178.03 g, 95% CI -315.26 to -40.81; 1190 infants; four studies; I<SUP>2</SUP> = 89%). In one study with data for 818 women, third- and fourth-degree perineal tears were increased in the induction group (RR 3.70, 95% CI 1.04 to 13.17).</P>
<P>For outcomes assessed using GRADE, we based our downgrading decisions on high risk of bias from lack of blinding and imprecision of effect estimates.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-03-21 11:37:55 +0000" MODIFIED_BY="Heather Maxwell">
<P>Induction of labour for suspected fetal macrosomia has not been shown to alter the risk of brachial plexus injury, but the power of the included studies to show a difference for such a rare event is limited. Also antenatal estimates of fetal weight are often inaccurate so many women may be worried unnecessarily, and many inductions may not be needed. Nevertheless, induction of labour for suspected fetal macrosomia results in a lower mean birthweight, and fewer birth fractures and shoulder dystocia. The unexpected observation in the induction group of increased perineal damage, and the plausible, but of uncertain significance, observation of increased use of phototherapy, both in the largest trial, should also be kept in mind.</P>
<P>Findings from trials included in the review suggest that to prevent one fracture it would be necessary to induce labour in 60 women. Since induction of labour does not appear to alter the rate of caesarean delivery or instrumental delivery, it is likely to be popular with many women. In settings where obstetricians can be reasonably confident about their scan assessment of fetal weight, the advantages and disadvantages of induction at or near term for fetuses suspected of being macrosomic should be discussed with parents.</P>
<P>Although some parents and doctors may feel the evidence already justifies induction, others may justifiably disagree. Further trials of induction shortly before term for suspected fetal macrosomia are needed. Such trials should concentrate on refining the optimum gestation of induction, and improving the accuracy of the diagnosis of macrosomia.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-03-23 15:02:27 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2016-03-22 12:42:07 +0000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2016-03-22 12:35:49 +0000" MODIFIED_BY="[Empty name]">
<P>Macrosomia is usually defined as a birthweight above 4000 g, although sometimes a higher cut-off is used (4500 g) (<LINK REF="REF-Delpapa-1991" TYPE="REFERENCE">Delpapa 1991</LINK>; <LINK REF="REF-Chatfield-2001" TYPE="REFERENCE">Chatfield 2001</LINK>: <LINK REF="REF-Ju-2009" TYPE="REFERENCE">Ju 2009</LINK>). Large-for-gestational-age fetuses are usually defined as those with a birthweight above the 90<SUP>th</SUP> percentile. Approximately 10% of pregnancies are affected by macrosomia, although estimates range from 3% to 15% in different settings (<LINK REF="REF-Chatfield-2001" TYPE="REFERENCE">Chatfield 2001</LINK>; <LINK REF="REF-Mohammadbeigi-2013" TYPE="REFERENCE">Mohammadbeigi 2013</LINK>).</P>
<P>Risk factors for giving birth to a large birthweight infant include a previous history of macrosomia, maternal obesity, maternal weight gain during pregnancy, multiparity and male fetus (<LINK REF="REF-Berard-1998" TYPE="REFERENCE">Berard 1998</LINK>; <LINK REF="REF-Cameron-2014" TYPE="REFERENCE">Cameron 2014</LINK>; <LINK REF="REF-Gaudet-2014" TYPE="REFERENCE">Gaudet 2014</LINK>).</P>
<P>Macrosomia is associated with a prolonged labour and maternal trauma along with a higher risk of birth injuries for the infant and longer-term adverse consequences (<LINK REF="REF-Ju-2009" TYPE="REFERENCE">Ju 2009</LINK>; <LINK REF="REF-Chatfield-2001" TYPE="REFERENCE">Chatfield 2001</LINK>; <LINK REF="REF-Mohammadbeigi-2013" TYPE="REFERENCE">Mohammadbeigi 2013</LINK>; <LINK REF="REF-Perlow-1996" TYPE="REFERENCE">Perlow 1996</LINK>). Women with large-for-dates fetuses are more likely to have labour augmentation and caesarean section, more serious perineal trauma, and more severe morbidity. High birthweight babies are at higher risk of sustaining injuries at the birth; risks of shoulder dystocia, fracture and brachial plexus injury are increased. There is an increased risk of fetal death and neonatal complications, and the risks of diabetes and cardiovascular disease in childhood and adult life are also elevated.</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-02-29 12:48:07 +0000" MODIFIED_BY="[Empty name]">
<P>Before caesarean section became reasonably safe, induction of labour for suspected macrosomia was performed because it was thought to prevent severe cephalo-pelvic disproportion and its associated maternal mortality and severe morbidity (<LINK REF="REF-Thiery-1989" TYPE="REFERENCE">Thiery 1989</LINK>).</P>
<P>Nowadays, some obstetricians induce labour at term when the fetus is estimated to be either large-for-gestational age or macrosomic. </P>
</INTERVENTION>
<THEORY MODIFIED="2016-03-22 12:40:01 +0000" MODIFIED_BY="[Empty name]">
<P>The purpose of labour induction at or shortly before term (37 to 40 weeks) in case of suspected fetal macrosomia is to reduce the likelihood of a difficult birth, possibly resulting in maternal or perinatal morbidity (<LINK REF="REF-Perlow-1996" TYPE="REFERENCE">Perlow 1996</LINK>). In particular, the risk of shoulder dystocia and the associated risk of neonatal trauma might be reduced by the intervention. Observational studies cast doubts on the effectiveness of such a policy (<LINK REF="REF-Friesen-1995" TYPE="REFERENCE">Friesen 1995</LINK>; <LINK REF="REF-Weeks-1995" TYPE="REFERENCE">Weeks 1995</LINK>), and have suggested that induction increases the risk of caesarean section without reducing birth injury.</P>
<P>Weighing the infant after the birth is the only accurate way to identify macrosomia. For a policy of induction to be effective, large-for-gestational-age fetuses must be reliably identified before they become macrosomic. Estimation of the fetal weight is difficult. Clinical estimation based on manual palpation of the uterus or uterine height measurements, as well as ultrasound scanning, is a method currently used to attempt to predict the fetal weight. The predictive value of such tests, especially for large fetuses, is poor (<LINK REF="REF-Coomarasamy-2005" TYPE="REFERENCE">Coomarasamy 2005</LINK>; <LINK REF="REF-Johnstone-1997" TYPE="REFERENCE">Johnstone 1997</LINK>). Magnetic Resonance Imaging (MRI) may be a more accurate method for estimating fetal weight, but at present the evidence for this is limited (<LINK REF="REF-Malin-2016" TYPE="REFERENCE">Malin 2016</LINK>). The accuracy of fetal weight estimation may be one of the limitations of a policy of induction of labour for suspected macrosomia.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-03-22 12:42:07 +0000" MODIFIED_BY="[Empty name]">
<P>In cases of suspected fetal macrosomia, it has not been clear whether a policy of induction of labour affects the risk of having caesarean section, instrumental birth, or perineal trauma, or improves outcomes for babies. The purpose of the review is to compare outcomes in women and infants where induction of labour has been compared with expectant management in randomised controlled trials. The review will be useful to guide clinical decisions and to allow women to make more informed choices about their care in cases of suspected large-for-dates fetus.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-02-29 12:50:37 +0000" MODIFIED_BY="[Empty name]">
<P>To evaluate a policy of labour induction for suspected fetal macrosomia on the risk of caesarean section, instrumental delivery and perineal trauma.</P>
<P>To evaluate a policy of labour induction for suspected fetal macrosomia on the risk of shoulder dystocia, birth trauma or asphyxia, and infant morbidity.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-03-22 12:34:43 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-03-21 12:59:24 +0000" MODIFIED_BY="Heather Maxwell">
<CRIT_STUDIES MODIFIED="2016-03-21 12:59:24 +0000" MODIFIED_BY="Heather Maxwell">
<P>We included all known randomised controlled trials evaluating labour induction for suspected fetal macrosomia. We planned to include cluster-randomised trials if any were identified. We planned to exclude quasi-randomised trials and studies using a cross-over design; the latter type of study is not an appropriate design for this type of intervention.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-03-21 08:16:09 +0000" MODIFIED_BY="Heather Maxwell">
<P>Term (37 to 40 weeks' gestation) pregnant women bearing a fetus suspected to be macrosomic and without other indications for induction of labour.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-02-29 12:51:36 +0000" MODIFIED_BY="[Empty name]">
<P>We considered studies comparing induction of labour with expectant management for inclusion in this review.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-03-21 11:50:36 +0000" MODIFIED_BY="Heather Maxwell">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-03-21 11:49:09 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<UL>
<LI>Caesarean section</LI>
<LI>Instrumental delivery</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Perinatal outcomes</HEADING>
<UL>
<LI>Shoulder dystocia</LI>
<LI>Brachial plexus injury</LI>
<LI>Fracture (any)</LI>
<LI>Neonatal asphyxia (low arterial cord blood pH, or low five-minute Apgar score</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-03-21 11:50:36 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<UL>
<LI>Spontaneous delivery</LI>
<LI>Third- and fourth-degree perineal tears</LI>
<LI>Maternal dissatisfaction (pain, sexual dysfunction)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Perinatal outcomes</HEADING>
<UL>
<LI>Mean birthweight (g)</LI>
<LI>Admission to neonatal intensive care unit</LI>
<LI>Intracranial haemorrhage</LI>
<LI>Convulsions</LI>
<LI>Perinatal mortality</LI>
<LI>Long-term disability in childhood</LI>
</UL>
<P>In this version of the review we have also reported findings for the following non pre-specified outcomes.</P>
<UL>
<LI>Significant shoulder dystocia (trialist defined)</LI>
<LI>Serious neonatal morbidity or death (composite outcome)</LI>
<LI>Use of phototherapy</LI>
<LI>Cephalohematoma</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-03-22 12:34:43 +0000" MODIFIED_BY="[Empty name]">
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-03-22 12:34:43 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (31 January 2016).</P>
<P>The Register is a database containing over 20,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate the Pregnancy and Childbirth Group&#8217;s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A> in <I>The Cochrane Library</I> and select the &#8216;<I>
<B>Specialized Register</B> </I>&#8217; section from the options on the left side of the screen.</P>
<P>Briefly, the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE (Ovid);</LI>
<LI>weekly searches of Embase (Ovid);</LI>
<LI>monthly searches of CINAHL (EBSCO);</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth Group review topic (or topics), and is then added to the Register. The Trials Search Co-ordinator searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (Included and Ongoing studies).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-11-25 10:45:12 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of retrieved studies and contacted trial authors for unpublished data.</P>
<P>We did not apply any language or date restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-03-21 12:57:45 +0000" MODIFIED_BY="Heather Maxwell">
<P>For methods used in the previous version of this review, <I>see </I>
<LINK REF="REF-Irion-1998" TYPE="REFERENCE">Irion 1998</LINK>.</P>
<P>For this update, we used the following methods, which are based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<STUDY_SELECTION MODIFIED="2015-07-30 11:01:39 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-03-21 11:53:47 +0000" MODIFIED_BY="Heather Maxwell">
<P>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion. Data were entered into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and checked for accuracy. Three of the review authors (MB, OI and JT) were investigators on trials included in the review; these authors were not involved in data extraction or assessing risk of bias for their trials.</P>
<P>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-03-21 11:54:48 +0000" MODIFIED_BY="Heather Maxwell">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Any disagreement was resolved by discussion or by involving a third assessor.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. web or telephone randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open list of random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>Blinding of staff or women to this type of intervention is not feasible. However, for each outcome we were able to consider whether lack of blinding was likely to affect results.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re-include missing data in the analyses which we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We described for each included study any important concerns we had about other possible sources of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <I>Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. In future updates, if more data become available, we will explore the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessing the quality of the body of evidence using the GRADE approach</HEADING>
<P>For this update the quality of the evidence has been evaluated using the GRADE approach as outlined in the <A HREF="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html">GRADE Handbook</A> in order to assess the quality of the body of evidence relating to the following outcomes.</P>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<UL>
<LI>Caesarean section</LI>
<LI>Instrumental delivery</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Perinatal outcomes</HEADING>
<UL>
<LI>Shoulder dystocia</LI>
<LI>Brachial plexus injury</LI>
<LI>Fracture (any)</LI>
<LI>Neonatal asphyxia (low arterial cord blood pH, or low five-minute Apgar score)</LI>
</UL>
<P>We used the <A HREF="http://www.gradepro.org/">GRADEpro</A> Guideline Development Tool to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create a &#8217;Summary of findings&#8217; table. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-03-21 11:55:01 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>We used the mean difference if outcomes were measured in the same way between trials. We planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-03-21 11:55:26 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>No cluster-randomised trials were identified by the search strategy. In future versions of the review, if such trials are identified, we will include cluster-randomised trials in the analyses along with individually-randomised trials. We will adjust their sample sizes using the methods described in the <I>Handbook</I> using an estimate of the intracluster correlation co-efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomised trials and individually-randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely.</P>
<P>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2015-11-26 12:15:56 +0000" MODIFIED_BY="[Empty name]">
<P>For included studies, levels of attrition were noted. In future updates, if more eligible studies are included, the impact of including studies with high levels of missing data in the overall assessment of treatment effect will be explored by using sensitivity analysis.</P>
<P>For all outcomes, analyses were carried out, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-03-21 11:55:32 +0000" MODIFIED_BY="Heather Maxwell">
<P>We assessed statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. Had we identified substantial heterogeneity (above 30%), we planned to explore it by pre-specified subgroup analysis; we did not carry out this further analysis in this version of the review due to insufficient data.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-03-21 11:55:42 +0000" MODIFIED_BY="Heather Maxwell">
<P>In future updates, if there are 10 or more studies in the meta-analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-03-21 11:55:42 +0000" MODIFIED_BY="Heather Maxwell">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar.</P>
<P>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary represents the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. For results where we have used random-effects analyses, the results have been presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-03-21 11:56:02 +0000" MODIFIED_BY="Heather Maxwell">
<P>Had we identified substantial heterogeneity, we planned to investigate it using subgroup analyses.</P>
<P>We planned the following subgroup analyses.</P>
<UL>
<LI>Clinical estimation based on palpation of the uterus versus ultrasound scanning.</LI>
<LI>Maternal diabetes versus no maternal diabetes.</LI>
<LI>Previous macrosomic infant versus no previous macrosomic infant.</LI>
</UL>
<P>We planned to use the primary outcomes in subgroup analysis.</P>
<P>In this version of the review too few studies were included to allow meaningful subgroup analyses. If sufficient data are available for future updates we will assess subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We will report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-03-21 12:57:45 +0000" MODIFIED_BY="Heather Maxwell">
<P>We planned to carry out sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, high attrition rates, or both, with poor-quality studies being excluded from the analyses in order to assess whether this makes any difference to the overall result. In this version of the review there were insufficient data to allow for these planned analyses.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-03-22 09:47:54 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-03-22 09:47:26 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2016-03-09 10:32:42 +0000" MODIFIED_BY="[Empty name]">
<P>We identified 10 reports of five trials. Four trials (nine reports) involving 1190 women, are included and one trial (<LINK REF="STD-Perlitz-2014" TYPE="STUDY">Perlitz 2014</LINK>) is in the <LINK TAG="ONGOING_STUDIES" TYPE="SECTION">Ongoing studies</LINK> section.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-03-22 09:47:26 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Study design and settings</HEADING>
<P>We included four randomised controlled trials (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>; <LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>).</P>
<P>The trial contributing most data to the review (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>), was a multi-centre RCT carried out in 19 hospitals in France, Switzerland and Belguim. Recruitment was between 2002 to 2009 and 822 women were randomised. The other three studies included in the review were carried out in Israel, USA and UK during the1990s had smaller sample sizes. In the study by <LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>, 273 women with a gestational age of 38 completed weeks or more were recruited. The <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK> and <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK> studies recruited women after 37 weeks (with 59 and 40 women randomised respectively).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>In two trials women were included when fetal weight, estimated by ultrasound examination, was between 4000 g and 4500 g (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>), or between 4000 g and 4750 g (<LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>). The third trial (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>) included women whose fetus was estimated to weigh more than the 97<SUP>th</SUP> percentile at the time of inclusion. The fourth trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>), included women whose fetus was estimated by sonograph to weigh more than the 95<SUP>th</SUP> centile. When estimated fetal weight was greater than 4500 g in the <LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK> trial, elective caesarean section was performed. Women with diabetes were excluded from two of these trials (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>). In the <LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK> trial, women with diabetes treated with insulin were excluded, although 10% of included participants had gestational diabetes mellitus (GDM) controlled by diet. Limited information is available for the <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK> pilot study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions and comparisons</HEADING>
<P>In the largest trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>), labour was induced between 37<SUP>+0</SUP> and 38<SUP>+6</SUP> weeks and within three days or randomisation. The method of induction was at the discretion of the attending physician and according to local protocol. Women with unfavourable cervix had cervical ripening with misoprostol or prostaglandin E2 (PGE2) followed by oxytocin infusion if labour had not started.</P>
<P>In the other trials, the method used for labour induction also depended on cervical status (prostaglandins for cervical ripening in the case of an unfavourable cervix, otherwise oxytocin infusion). Women in the expectant management group underwent induction of labour upon completion of 42 weeks of gestation in the <LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK> trial.</P>
<P>We obtained additional (unpublished) information for the four included studies. All the results of the Libby pilot study are unpublished (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-03-09 10:33:22 +0000" MODIFIED_BY="[Empty name]">
<P>There are no excluded studies.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-03-21 11:59:54 +0000" MODIFIED_BY="Heather Maxwell">
<P>See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> for a summary of 'Risk of bias' assessments in studies.</P>
<ALLOCATION MODIFIED="2016-03-21 11:58:08 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Generation of the randomisation sequence</HEADING>
<P>All studies used a computer-generated table of random numbers or Internet-based randomisation (low risk of bias).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>In two of the studies, sealed, sequentially numbered, opaque envelopes were used (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>) and the <LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK> trial used a central randomisation service (all three studies assessed as low risk of bias). In the other report, the method for concealment of the random allocation was not described (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>) (unclear risk of bias).</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2016-03-21 11:59:04 +0000" MODIFIED_BY="Heather Maxwell">
<P>Although blinding of women and staff was not reported in three studies (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>) we have assumed that it had not been attempted. It was reported to be not possible in one study (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>); all four studies were assessed as high risk of bias for performance bias. There was no mention of any attempt to blind outcome assessors in three studies (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>), and again, we assumed that it had not been attempted and assessed these studies as high risk of bias for detection bias. In one study it was stated that the assessment of the primary outcome was by investigators masked to group allocation (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>); we assessed this study as unclear risk of bias for this domain as most outcomes would be recorded in case notes by staff aware of the intervention group.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-03-21 11:59:27 +0000" MODIFIED_BY="Heather Maxwell">
<P>In one study (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>), a few women (six in the induction group and five in the expectant group) were excluded from the study after randomisation, either because of withdrawal of consent or because they were lost to follow-up. Apart from the fact that these women were excluded, an intention-to-treat analysis was performed (low risk of bias). In the LIBBY pilot (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>), 29/30 women in the induction group had induction, compared to 14/29 in the expectant management group; analysis was however performed on an intention-to-treat basis (low risk of bias). In the <LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK> study there was very little attrition bias (822 women randomised; 818 included in the analysis, two women in each group were lost to follow-up) (low risk of bias). In the fourth study (<LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>), there was limited information in the abstract report (unclear risk of bias).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-03-21 11:59:54 +0000" MODIFIED_BY="Heather Maxwell">
<P>All expected outcome results were reported in one study (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>) (low risk of bias). In the <LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK> trial, we had access to the trial protocol and most outcomes reported in the main trial report were pre-specified, there were some changes during the study as more centres were recruited (unclear risk of bias). It was not possible to tell if selective outcome reporting was apparent in the two remaining studies (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>) (unclear risk of bias).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2015-12-02 11:22:56 +0000" MODIFIED_BY="[Empty name]">
<P>Baseline characteristics were similar between groups and no other bias was apparent in one study (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>) (low risk of bias). It was not possible to tell if other sources of bias were apparent in the remaining three studies (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>; <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>) (unclear risk of bias).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-03-22 09:47:54 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Induction of labour versus expectant management for suspected fetal macrosomia (four studies, 1190 women)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>We identified four trials (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>; <LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>), involving a total of 1190 women.</P>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<P>Compared to expectant management, induction of labour for suspected macrosomia has not been shown to reduce the risk of <B>caesarean section</B> (risk ratio (RR) 0.91, 95% confidence interval (CI) 0.76 to 1.09; 1190 women; four studies, <I>moderate-quality evidence</I>) <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>, or<B> instrumental delivery</B> (RR 0.86, 95% CI 0.65 to 1.13; 1190 women; four studies, <I>low-quality evidence</I>), <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Perinatal outcomes</HEADING>
<P>The risks of <B>shoulder dystocia</B> and <B>fracture (any)</B> were lower in the induction group (RR 0.60, 95% CI 0.37 to 0.98; 1190 women; four trials, <I>moderate-quality evidence; </I>and RR 0.20, 95% CI 0.05 to 0.79; 1190 women; four studies, <I>high-quality evidence, </I>respectively) <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>. However, there were no clear differences between groups for <B>brachial plexus injury</B>, although this outcome was infrequent with one trial reporting two cases of brachial plexus injury in the expectant management group (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>) (RR 0.21, 95% CI 0.01 to 4.28; four studies, 1190 women, <I>low-quality evidence</I>) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). There was no strong evidence of any difference between groups for measures of neonatal asphyxia: <B>low infant Apgar scores (less than seven)</B> or <B>low arterial cord blood pH</B> (RR 1.51, 95% CI 0.25 to 9.02; 858 infants; two trials, <I>low-quality evidence</I>; and, RR 1.01, 95% CI 0.46 to 2.22; 818 infants; one trial, <I>moderate-quality evidence,</I> respectively), <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<P>All four studies reported <B>spontaneous delivery</B> and there was no clear evidence of differences between groups (RR 1.09, 95% CI 0.99 to 1.20; 1190 women) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). Two studies reported <B>third- and fourth-degree perineal</B> tears, but only one had estimable data (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>); in this study the number of women with tears was increased in the induction of labour group, although the 95% CI was wide for this outcome (RR 3.70, 95% CI 1.04 to 13.17; 858 women), <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>.</P>
<P>No information is available about <B>maternal dissatisfaction (pain, sexual dysfunction)</B>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Infant outcomes</HEADING>
<P>Three of the studies reported <B>perinatal mortality</B>, but there were no events reported in either group.</P>
<P>When cranial sonography was performed, a similar proportion of newborns with <B>intraventricular haemorrhage</B> was observed between the intervention and the control groups (RR 1.06, 95% CI 0.19 to 5.96; 933 infants; three studies), <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>. One study reported on the outcome <B>infant convulsions</B> but there were no events in either group <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>. There were no clear differences between groups for admission to neonatal intensive care in two studies reporting this outcome (RR 0.66, 95% CI 0.35 to 1.24; 858 infants; two studies) <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>.</P>
<P>In the pooled analysis, <B>mean infant birthweight</B> was lower in the induction group, although there were high levels of statistical heterogeneity for this outcome (mean difference (MD) -178.03 g, 95% CI -315.26 to -40.81; 1190 infants; four studies; I<SUP>2</SUP> = 89%) <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>.). For one study (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>), data for this outcome were reported as median and interquartile range; in order to use these data in the meta-analysis, we entered the median as the measure of central tendency and estimated the standard deviations from the interquartile range. As we had estimated the standard deviations (and assumed that they were the same in both the intervention and control groups), we also carried out a sensitivity analysis using the standard deviations reported in the largest trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>); the sensitivity analysis showed similar results (MD -169.81, 95% CI -321.36 to -18.25) <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>.</P>
<P>It must be noted that in two of the trials (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>), despite induction of labour in the intervention group, groups were similar with regard to mean birthweight. The contrast between groups was larger in the <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK> (-295 g median difference between groups) and <LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK> trials (-287 g difference).</P>
<P>There was no information on <B>long-term disability in childhood</B> in any of the studies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Non pre-specified outcomes</HEADING>
<P>The trial contributing most data (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>) reported outcomes that were not pre-specified in the protocol for this review.</P>
<P>First, clinically significant shoulder dystocia, had been pre-specified as a secondary outcome in the trial, and defined as "difficulty with delivery of the shoulders that was not resolved by the McRoberts' manoeuvre (flexion of the maternal thighs), usually combined with suprapubic pressure". It was reduced in the induction of labour group (RR 0.32, 95% CI 0.12 to 0.85; infants = 818; one study) (<LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>). The authors of the trial had also pre-specified their primary fetal trial outcome as a composite of significant should dystocia and a range of birth injuries and death. That composite outcome was also reduced (RR 0·32 95% CI 0·15 to 0·71; infants = 818) (<LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>).</P>
<P>A further outcome reported by <LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>, was the use of neonatal phototherapy. Although this had been pre-specified neither in the trial nor in this review, it was increased in the induction of labour group; induction 45 (11%) versus control 27 (7%), nominal P = 0·03 (RR 1.68, 95% CI 1.07 to 2.66; infants = 818) )(<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>).</P>
<P>Finally, <LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK> reported cephalohematoma, and there was no clear evidence that this outcome differed between groups (RR 2.07, 95% CI 0.53 to 8.13; infants = 273) (<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>.</P>
<P>Insufficient data were available to allow us to perform planned subgroup analysis.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-03-21 12:05:12 +0000" MODIFIED_BY="Heather Maxwell">
<SUMMARY_OF_RESULTS MODIFIED="2016-03-21 12:05:12 +0000" MODIFIED_BY="Heather Maxwell">
<P>The review included four randomised controlled trials involving 1190 women, although one trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>) with 822 women contributed most of the data.</P>
<P>Induction of labour shortly before term for suspected fetal macrosomia in non-diabetic women reduces both neonatal fractures and shoulder dystocia. The number needed to treat per fracture prevented is 60. Specifically, the evidence does not seem to suggest that a policy of induction increases the risk of caesarean section or instrumental birth, and may slightly reduce the former. Neonatal brachial plexus injury was reported for two babies in the control group, but the power of the included studies to show a difference between groups for such a rare event is limited. In one trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>), an increase in phototherapy in the induction group, was observed, but this was not pre-specified in that trial nor in this review, and none of the infants involved had bilirubin levels over the normal cut-off for phototherapy in the trial centres, namely 350 mmol/L, and the nominal statistical test result took no account of multiple testing. We are therefore uncertain of the clinical significance of this finding. All other neonatal outcomes were similar between groups. One trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>), also pre-specified a composite primary fetal trial outcome of significant shoulder dystocia and other types of birth injury. Although not pre-specified in our review protocol, it was significantly reduced in the induction group in that trial. Finally, there was an unanticipated increase in third- and fourth-degree perineal tears in the induction group in the same trial.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-03-21 12:03:26 +0000" MODIFIED_BY="Heather Maxwell">
<P>The meta-analysis of the effect of induction on mean birthweight showed a high level of heterogeneity, which was explained by differences in trial design. Two studies (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>) included pregnancies around 40 weeks with an estimated fetal weight of more than 4000 g. As a result, despite induction of labour, the groups were similar with regard to gestational age at delivery and mean birthweight. The intervention was probably not performed early enough to avoid excessive birthweight. The two trials (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>; <LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>) that included women at an earlier gestational age observed a larger contrast in birthweight between groups.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-03-21 12:03:32 +0000" MODIFIED_BY="Heather Maxwell">
<P>The overall quality of the evidence of the three smaller trials was at best moderate. However, the new trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>), apart from lack of blinding was assessed as being at low risk of bias and as this trial now dominates the review, we have judged that overall findings were at fairly low risk of bias. This is summarised in the 'Risk of bias' summary figures, <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>. We used <A HREF="http://www.gradepro.org/">GRADEpro</A> software to grade evidence for our primary outcomes; for fracture the evidence was rated as high quality while for other primary outcomes, evidence was downgraded to moderate or low quality due to risk of bias relating to lack of blinding or imprecision of effect estimates.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-11-18 11:03:28 +0000" MODIFIED_BY="[Empty name]">
<P>We are aware that there is the potential to introduce bias at every stage in the review process and we took steps to minimise bias. At least two review authors independently assessed each study for possible inclusion, and carried out data extraction and assessment of study quality for included studies. Assessing risk of bias is a matter of judgment rather than an exact science and it is possible that a different review team may have made different decisions.</P>
<P>Two review team authors (Boulvain and Irion) are authors of the recently included trial (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>), and a third (Thornton) is an author of another included trial (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>). They were not involved in carrying out data extraction or assessing risk of bias for the trials which they had authored.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-03-21 12:03:47 +0000" MODIFIED_BY="Heather Maxwell">
<P>The results of this review disagree with another non-Cochrane systematic review which examined induction of labour versus expectant management for suspected fetal macrosomia (<LINK REF="REF-Sanchez_x002d_Ramos-2002" TYPE="REFERENCE">Sanchez-Ramos 2002</LINK>). That review included both randomised controlled trials and observational studies. The authors found no difference in rates of caesarean section, operative vaginal delivery or shoulder dystocia between induction of labour and expectant management groups for the two trials (313 women) included in their systematic review. Both trials included in the <LINK REF="REF-Sanchez_x002d_Ramos-2002" TYPE="REFERENCE">Sanchez-Ramos 2002</LINK> systematic review are also included in this review (<LINK REF="STD-Gonen-1997" TYPE="STUDY">Gonen 1997</LINK>; <LINK REF="STD-Tey-1995" TYPE="STUDY">Tey 1995</LINK>). However, the observational data included in the review (<LINK REF="REF-Sanchez_x002d_Ramos-2002" TYPE="REFERENCE">Sanchez-Ramos 2002</LINK>) suggested an increased caesarean delivery rate without improving perinatal outcomes for labour induction.</P>
<P>The finding that a policy of near term induction for suspected macrosomia does not increase caesarean section rates will be counterintuitive for many obstetricians and midwives who have long believed, from non-randomised studies, that induction increases the rate of caesarean delivery. However, it is in agreement with three recent non-Cochrane reviews (<LINK REF="REF-Mishanina-2014" TYPE="REFERENCE">Mishanina 2014</LINK>; <LINK REF="REF-Saccone-2015" TYPE="REFERENCE">Saccone 2015</LINK>; <LINK REF="REF-Wood-2014" TYPE="REFERENCE">Wood 2014</LINK>), which measured the effect of induction for a range of indications on caesarean. All three reviews restricted their analyses to randomised controlled trials. The two which included the largest number of trials (<LINK REF="REF-Mishanina-2014" TYPE="REFERENCE">Mishanina 2014</LINK>; <LINK REF="REF-Wood-2014" TYPE="REFERENCE">Wood 2014</LINK>), 157 and 37 trials respectively, reported that induction significantly reduced caesarean rates and the other review (<LINK REF="REF-Saccone-2015" TYPE="REFERENCE">Saccone 2015</LINK>), which that included only six trials reported no significant effect. This external evidence gives us confidence in our conclusion that the policy of induction for suspected macrosomia does not increase caesareans rates. Since our observed point estimate for the effect on caesarean of a risk ratio (RR) of 0.91 is close to the RR of 0.88 taken from the largest systematic review (<LINK REF="REF-Mishanina-2014" TYPE="REFERENCE">Mishanina 2014</LINK>), our best estimate is that a policy of induction may slightly reduce the number of caesarean births.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-03-23 15:02:27 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2016-03-23 15:02:27 +0000" MODIFIED_BY="[Empty name]">
<P>There is now evidence that a systematic policy of labour induction for suspected fetal macrosomia in non-diabetic women reduces mean birthweight and birth fractures. Although the trials are too small to show a meaningful reduction in brachial plexus injury, we did not observe any adverse effect in terms of an increased rate of caesarean section or instrumental birth.</P>
<P>The evidence justifies a policy of telling women about these advantages, and the lack of any clear evidence that induction affects the way the baby is born. At the same time, there may be disadvantages of induction, and findings from this review suggest third- and fourth-degree perineal tears may be increased in the induction group.</P>
<P>The exact gestation at which doctors and parents will decide on induction cannot be specified from these data. Induction between 38 + 0 and 38 + 6 weeks, i.e. at the later gestation considered, is likely to minimise the risks of iatrogenic prematurity but may not achieve much benefit in terms of birthweight and birth injury reduction. Induction at 37 weeks may have the opposite trade-off of risks and benefits.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-03-21 12:04:02 +0000" MODIFIED_BY="Heather Maxwell">
<P>Although some parents and doctors may feel the evidence already justifies induction, others may justifiably disagree. Further trials of induction shortly before term for suspected fetal macrosomia remain justified. Such trials should concentrate on refining the optimum gestation of induction, and improving the accuracy of the diagnosis of macrosomia.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-03-09 12:08:20 +0000" MODIFIED_BY="[Empty name]">
<P>We thank Dr A Tey, Dr O Gonen and Prof J Thornton for providing us with unpublished information on their studies.</P>
<P>TD is supported by the National Institute for Health Research (NIHR) Cochrane Programme Grant Project: 13/89/05 &#8211; Pregnancy and childbirth systematic reviews to support clinical guidelines. </P>
<P>This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding and Cochrane Programme Grant funding (13/89/05) to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.</P>
<P>As part of the pre-publication editorial process, this review has been commented on by four peers (an editor and three referees who are external to the editorial team), a member of the Pregnancy and Childbirth Group's international panel of consumers and the Group's Statistical Adviser.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-03-29 08:45:24 +0100" MODIFIED_BY="[Empty name]">
<P>Two of authors (MB and OI) are on one of the included trials (<LINK REF="STD-Boulvain-2015" TYPE="STUDY">Boulvain 2015</LINK>) and a third (JT) on another (<LINK REF="STD-LIBBY-1998" TYPE="STUDY">LIBBY 1998</LINK>). They were not involved in carrying out data extraction or assessing risk of bias for their own trials. Data extraction and assessment of risk of bias was for these trials was carried out by Leanne Jones and Therese Dowswell, Research Associates in the Cochrane Pregnancy and Childbirth Group.</P>
<P>Michel Boulvain was an invited speaker at a DIP congress on gestational diabetes and received accommodation expenses.</P>
<P>Therese Dowswell is employed by the University of Liverpool on an NIHR Cochrane Programme Grant (13/89/05) to work on a range of Cochrane Reviews. In the past 3 years her institution has received a grant from WHO to support her working on other Cochrane reviews. The Funders have no influence on the content or conclusions of the relevant Cochrane reviews.</P>
<P>Olivier Irion receives salary support from the University Hospitals of Geneva and the University of Geneva. He has received money to provide expert (extra-) judiciary reports unrelated to this review. He has also been refunded for travel and meetings fees by his institution and the Swiss Ob-Gyn society and received payment from the University of Geneva for teaching (around 6 hours per year) on courses provided to the Geneva Midwives school.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-11-23 10:23:23 +0000" MODIFIED_BY="[Empty name]">
<P>Olivier Irion and Michel Boulvain wrote the protocol, collected the data and contributed to writing this updated review. Jim Thornton collected the data and contributed to writing this update. Therese Dowswell collected the data and contributed to writing this update.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-03-21 12:05:42 +0000" MODIFIED_BY="Heather Maxwell">
<P>The methods have been updated in accordance with the current standard methods for Cochrane Pregnancy and Childbirth Group.</P>
<P>Methods/outcomes - we have separated our outcomes into primary and secondary outcomes. We have also revised our list of outcomes. In the earlier version of this review the list of outcomes was as follows.</P>
<UL>
<LI>Maternal outcomes - proportion of women having caesarean section; instrumental delivery and spontaneous delivery.</LI>
<LI>Perinatal outcomes - shoulder dystocia; brachial plexus injury; clavicular fracture; intracranial haemorrhage, diagnosed by sonography.</LI>
</UL>
<P>For this update, we have specified the following outcomes.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<UL>
<LI>Caesarean section</LI>
<LI>Instrumental delivery</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Perinatal outcomes</HEADING>
<UL>
<LI>Shoulder dystocia</LI>
<LI>Brachial plexus injury</LI>
<LI>Fracture (any)</LI>
<LI>Neonatal asphyxia (low arterial cord blood pH, or low five-minute Apgar score)</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<UL>
<LI>Spontaneous delivery</LI>
<LI>Third- and fourth-degree perineal tears</LI>
<LI>Maternal dissatisfaction (pain, sexual dysfunction)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Perinatal outcomes</HEADING>
<UL>
<LI>Mean birthweight (g)</LI>
<LI>Admission to neonatal intensive care unit</LI>
<LI>Intracranial haemorrhage</LI>
<LI>Convulsions</LI>
<LI>Perinatal mortality</LI>
<LI>Long-term disability in childhood</LI>
</UL>
<P>We have also reported findings for the following non pre-specified outcomes.</P>
<UL>
<LI>Significant shoulder dystocia (trialist defined)</LI>
<LI>Serious neonatal morbidity or death (composite outcome)</LI>
<LI>Use of phototherapy</LI>
<LI>Cephalohematoma</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-05-23 11:06:45 +0100" MODIFIED_BY="Frances Kellie">
<STUDIES MODIFIED="2016-03-20 16:51:39 +0000" MODIFIED_BY="Heather Maxwell">
<INCLUDED_STUDIES MODIFIED="2016-03-20 16:51:39 +0000" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="MIX" ID="STD-Boulvain-2015" MODIFIED="2016-03-20 16:51:16 +0000" MODIFIED_BY="Heather Maxwell" NAME="Boulvain 2015" YEAR="2012">
<REFERENCE MODIFIED="2015-07-28 10:53:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Boulvain M, Senat MV, Perrotin F, Winer N, Beucher G, Subtil D, et al</AU>
<TI>Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2015</YR>
<VL>385</VL>
<NO>9987</NO>
<PG>2600-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743456"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-03-20 16:51:16 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boulvain M, Senat MV, Rozenberg P, Irion O</AU>
<TI>Induction of labor or expectant management for large-for-dates fetuses: a randomized controlled trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2012</YR>
<VL>206</VL>
<NO>Suppl 1</NO>
<PG>S2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743457"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-09 16:18:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Boulvain M</AU>
<TI>Induce or wait for estimated macrosomia (DAME)</TI>
<SO>Personal communication</SO>
<YR>2002</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743458"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-25 10:54:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rozenberg P</AU>
<TI>DAME: induction of labor or waiting for suspicion fetal macrosomia</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [21 March 2006]</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743459"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-05-13 10:19:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2743455"/><IDENTIFIER MODIFIED="2013-05-13 10:19:00 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00190320"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Gonen-1997" MODIFIED="2016-03-20 16:51:39 +0000" MODIFIED_BY="Heather Maxwell" NAME="Gonen 1997" YEAR="1997">
<REFERENCE MODIFIED="2016-03-20 16:51:39 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[8362]&lt;/p&gt;" NOTES_MODIFIED="2016-03-20 16:51:39 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gonen O, Rosen DJD, Dolfin Z, Kaneti HY, Katzenstein M, Regev R, et al</AU>
<TI>Induction of labor versus expectant management in macrosomia: a prospective randomized study</TI>
<SO>Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland</SO>
<YR>1994</YR>
<PG>374</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743461"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-25 10:57:54 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[9541]&lt;/p&gt;" NOTES_MODIFIED="2015-11-25 10:57:54 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gonen O, Rosen DJD, Dolfin Z, Tepper R, Markov S, Fejgin MD</AU>
<TI>Induction of labor versus expectant management in macrosomia: a randomized study</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1997</YR>
<VL>89</VL>
<PG>913-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743462"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2743460"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-LIBBY-1998" MODIFIED="2015-07-16 00:08:13 +0100" MODIFIED_BY="[Empty name]" NAME="LIBBY 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Kean LH</AU>
<TI>Leave alone or induce for the big baby (LIBBY)</TI>
<SO>National Research Register. www.update-software.com/NRR</SO>
<YR>(accessed 10 September 2000)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743464"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Thornton J</AU>
<TI>Unpublished data of the LIBBY pilot (as supplied October 2006)</TI>
<SO>Data on file</SO>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743465"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-07-16 00:08:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2743463"/><IDENTIFIER MODIFIED="2015-07-16 00:08:13 +0100" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="ISRCTN98146741"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Tey-1995" NAME="Tey 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;[8701]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tey A, Eriksen NL, Blanco JD</AU>
<TI>A prospective randomized trial of induction versus expectant management in nondiabetic pregnancies with fetal macrosomia [abstract]</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1995</YR>
<VL>172</VL>
<PG>293</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743467"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2743466"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES MODIFIED="2015-11-23 11:46:35 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2016-02-25 14:20:43 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Perlitz-2014" MODIFIED="2016-02-25 14:20:43 +0000" MODIFIED_BY="[Empty name]" NAME="Perlitz 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-02-25 14:20:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Perlitz Y</AU>
<TI>Induction of labor versus expectant management of large for gestational age/macrosomic babies at term. a multi-center randomized trial</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 25 February 2016]</SO>
<YR>2014</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2743469"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2743468"/><IDENTIFIER TYPE="CTG" VALUE="NCT02315820"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-03-29 11:11:35 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2016-03-29 11:11:35 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Berard-1998" MODIFIED="2016-03-08 14:48:04 +0000" MODIFIED_BY="[Empty name]" NAME="Berard 1998" NOTES="&lt;p&gt;Berard J&lt;br&gt;Dufour P&lt;br&gt;Vinatier D&lt;br&gt;Subtil D&lt;br&gt;Vanderstichele S&lt;br&gt;Monnier JC&lt;br&gt;Puech F&lt;/p&gt;" NOTES_MODIFIED="2016-03-08 14:48:04 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Berard J, Dufour P, Vinatier D, Subtil D, Vanderstichele S, Monnier JC, et al</AU>
<TI>Fetal macrosomia: risk factors and outcome. A study of the outcome concerning 100 cases &gt;4500 g</TI>
<SO>European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology</SO>
<YR>1998</YR>
<VL>77</VL>
<NO>1</NO>
<PG>51-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cameron-2014" MODIFIED="2016-03-08 14:48:18 +0000" MODIFIED_BY="[Empty name]" NAME="Cameron 2014" NOTES="&lt;p&gt;Cameron CM&lt;br&gt;Shibl R&lt;br&gt;McClure RJ&lt;br&gt;Ng SK&lt;br&gt;Hills AP&lt;/p&gt;" NOTES_MODIFIED="2016-03-08 14:48:18 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Cameron CM, Shibl R, McClure RJ, Ng SK, Hills AP</AU>
<TI>Maternal pregravid body mass index and child hospital admissions in the first 5 years of life: results from an Australian birth cohort</TI>
<SO>International Journal of Obesity</SO>
<YR>2014</YR>
<VL>38</VL>
<NO>10</NO>
<PG>1268-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chatfield-2001" MODIFIED="2016-02-29 10:09:48 +0000" MODIFIED_BY="[Empty name]" NAME="Chatfield 2001" NOTES="&lt;p&gt;Chatfield J&lt;/p&gt;" NOTES_MODIFIED="2016-02-29 10:09:48 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Chatfield J</AU>
<TI>ACOG issues guidelines on fetal macrosomia. American College of Obstetricians and Gynecologists</TI>
<SO>American Family Physician</SO>
<YR>2001</YR>
<VL>64</VL>
<NO>1</NO>
<PG>169-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chitty-1994" MODIFIED="2016-03-29 11:11:35 +0100" MODIFIED_BY="[Empty name]" NAME="Chitty 1994" TYPE="JOURNAL_ARTICLE">
<AU>Chitty LS. Altmann DG. Henderson A. Campbell S</AU>
<TI>Charts of fetal size: 3. Abdominal measurements</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>1994</YR>
<VL>101</VL>
<PG>125-131</PG>
<IDENTIFIERS MODIFIED="2016-03-29 11:08:38 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-03-29 11:08:38 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1111/j.1471-0528.1994.tb13077.x"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Coomarasamy-2005" MODIFIED="2016-03-29 11:11:18 +0100" MODIFIED_BY="[Empty name]" NAME="Coomarasamy 2005" TYPE="JOURNAL_ARTICLE">
<AU>Coomarasamy A, Connock M, Thornton JG, Khan KS</AU>
<TI>Accuracy of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2005</YR>
<VL>112</VL>
<NO>11</NO>
<PG>1461-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Delpapa-1991" NAME="Delpapa 1991" TYPE="JOURNAL_ARTICLE">
<AU>Delpapa EH, Muller-Heubach E</AU>
<TI>Pregnancy outcome following ultrasound diagnosis of macrosomia</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1991</YR>
<VL>78</VL>
<PG>340-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Friesen-1995" NAME="Friesen 1995" TYPE="JOURNAL_ARTICLE">
<AU>Friesen CD, Miller AN, Rayburn WF</AU>
<TI>Influence of spontaneous or induced labor on delivering the macrosomic fetus</TI>
<SO>American Journal of Perinatology</SO>
<YR>1995</YR>
<VL>12</VL>
<PG>63-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gaudet-2014" MODIFIED="2016-03-20 16:57:19 +0000" MODIFIED_BY="Heather Maxwell" NAME="Gaudet 2014" NOTES="&lt;p&gt;Gaudet L&lt;br&gt;Wen SW&lt;br&gt;Walker M&lt;/p&gt;" NOTES_MODIFIED="2016-03-20 16:57:19 +0000" NOTES_MODIFIED_BY="Heather Maxwell" TYPE="JOURNAL_ARTICLE">
<AU>Gaudet L, Wen SW, Walker M</AU>
<TI>The combined effect of maternal obesity and fetal macrosomia on pregnancy outcomes</TI>
<SO>Journal of Obstetrics &amp; Gynaecology Canada: JOGC</SO>
<YR>2014</YR>
<VL>36</VL>
<NO>9</NO>
<PG>776-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-11-19 14:42:28 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnstone-1997" NAME="Johnstone 1997" TYPE="JOURNAL_ARTICLE">
<AU>Johnstone FD</AU>
<TI>Prediction of macrosomia in diabetic pregnancy</TI>
<SO>Contemporary Reviews in Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>2</VL>
<PG>113-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ju-2009" MODIFIED="2016-03-08 14:49:21 +0000" MODIFIED_BY="[Empty name]" NAME="Ju 2009" NOTES="&lt;p&gt;Ju H&lt;br&gt;Chadha Y&lt;br&gt;Donovan T&lt;br&gt;O'Rourke P&lt;/p&gt;" NOTES_MODIFIED="2016-03-08 14:49:21 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Ju H, Chadha Y, Donovan T, O'Rourke P</AU>
<TI>Fetal macrosomia and pregnancy outcomes</TI>
<SO>Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2009</YR>
<VL>49</VL>
<NO>5</NO>
<PG>504-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malin-2016" MODIFIED="2016-03-21 14:01:30 +0000" MODIFIED_BY="[Empty name]" NAME="Malin 2016" TYPE="JOURNAL_ARTICLE">
<AU>Malin GL, Bugg GJ, Takwoingi Y, Thornton JG, Jones NW</AU>
<TI>Antenatal magnetic resonance imaging versus ultrasound for predicting neonatal macrosomia: a systematic review and meta-analysis</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2016</YR>
<VL>123</VL>
<NO>1</NO>
<PG>77-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mishanina-2014" MODIFIED="2016-03-21 13:58:58 +0000" MODIFIED_BY="[Empty name]" NAME="Mishanina 2014" TYPE="JOURNAL_ARTICLE">
<AU>Mishanina E, Rogozinska E, Thatthi T, Uddin-Khan R, Khan KS, Meads C</AU>
<TI>Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>2014</YR>
<VL>186</VL>
<NO>9</NO>
<PG>665-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mohammadbeigi-2013" MODIFIED="2016-02-29 10:18:33 +0000" MODIFIED_BY="[Empty name]" NAME="Mohammadbeigi 2013" TYPE="JOURNAL_ARTICLE">
<AU>Mohammadbeigi A, Farhadifar F, Soufi Zadeh N, Mohammadsalehi N, Rezaiee M, Aghaei M</AU>
<TI>Fetal macrosomia: risk factors, maternal, and perinatal outcome</TI>
<SO>Annals of Medical Health Science Research</SO>
<YR>2013</YR>
<VL>3</VL>
<NO>4</NO>
<PG>546-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perlow-1996" NAME="Perlow 1996" TYPE="JOURNAL_ARTICLE">
<AU>Perlow JH, Wigton T, Hart J, Strassner HT, Nageotte MP, Wolk BM</AU>
<TI>Birth trauma: a five-year review of incidence and associated perinatal factors</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1996</YR>
<VL>41</VL>
<PG>754-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2015-06-17 14:53:54 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Saccone-2015" MODIFIED="2016-03-21 13:59:08 +0000" MODIFIED_BY="[Empty name]" NAME="Saccone 2015" TYPE="JOURNAL_ARTICLE">
<AU>Saccone G, Berghella V</AU>
<TI>Induction of labor at full term in uncomplicated singleton gestations: a systematic review and metaanalysis of randomized controlled trials</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2015</YR>
<VL>213</VL>
<NO>5</NO>
<PG>629-36</PG>
<IDENTIFIERS MODIFIED="2015-11-25 11:02:49 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Sanchez_x002d_Ramos-2002" MODIFIED="2013-05-13 10:21:55 +0100" MODIFIED_BY="[Empty name]" NAME="Sanchez-Ramos 2002" TYPE="JOURNAL_ARTICLE">
<AU>Sanchez-Ramos L, Bernstein S, Kaunitz AM</AU>
<TI>Expectant management versus labor induction for suspected fetal macrosomia: a systematic review</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2002</YR>
<VL>100</VL>
<NO>5 Pt 1</NO>
<PG>997-1002</PG>
<IDENTIFIERS MODIFIED="2013-04-09 15:55:49 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="12423867"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Thiery-1989" MODIFIED="2013-05-13 10:22:10 +0100" MODIFIED_BY="[Empty name]" NAME="Thiery 1989" TYPE="BOOK_SECTION">
<AU>Thiery M, Baines CJ, Keirse MJNC</AU>
<TI>The development of methods for inducing labour</TI>
<SO>Effective Care in Pregnancy and Childbirth</SO>
<YR>1989</YR>
<PG>969</PG>
<ED>Chalmers I, Enkin MW, Keirse MJNC</ED>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weeks-1995" NAME="Weeks 1995" TYPE="JOURNAL_ARTICLE">
<AU>Weeks JW, Pitman T, Spinnato JA</AU>
<TI>Fetal macrosomia: does antenatal prediction affect delivery route and birth outcomes?</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1995</YR>
<VL>173</VL>
<PG>1215-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wood-2014" MODIFIED="2015-11-25 11:04:11 +0000" MODIFIED_BY="[Empty name]" NAME="Wood 2014" TYPE="JOURNAL_ARTICLE">
<AU>Wood S, Cooper S, Ross S</AU>
<TI>Does induction of labour increase the risk of caesarean section? A systematic review and meta-analysis of trials in women with intact membranes</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2014</YR>
<VL>121</VL>
<NO>6</NO>
<PG>674-85</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-03-20 16:44:54 +0000" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Irion-1998" MODIFIED="2016-03-20 16:44:54 +0000" MODIFIED_BY="Heather Maxwell" NAME="Irion 1998" TYPE="COCHRANE_REVIEW">
<AU>Irion O, Boulvain M</AU>
<TI>Induction of labour for suspected fetal macrosomia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2013-04-09 16:21:50 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2013-04-09 16:21:50 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000938"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-03-29 11:06:33 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-03-29 11:06:33 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-11-26 12:36:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boulvain-2015">
<CHAR_METHODS MODIFIED="2015-11-26 12:34:46 +0000" MODIFIED_BY="[Empty name]">
<P>Multi-centre randomised controlled trial in collaboration with 19 teaching hospitals, members of GROG group, in France, Switzerland and Belguim. Recruitment 2002-2009.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-11-26 12:34:53 +0000" MODIFIED_BY="[Empty name]">
<P>822 women randomised. Women with singleton fetus with cephalic presentation and no contraindications to vaginal delivery. Women were screened between 36-38 weeks' gestation and those with a fetus with an estimated weight above the 95<SUP>th</SUP> percentile at 37 to 38 weeks of gestation, confirmed clinically and then by sonography were included.</P>
<P>Exclusion criteria: any contraindication to induction of labour or vaginal delivery or a history of caesarean section, neonatal trauma or shoulder dystocia, severe urinary or faecal incontinence, or insulin treated diabetes. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-11-26 12:35:30 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention: 409 women allocated to induction of labour. Labour was induced between 37<SUP>+0</SUP> and 38<SUP>+6</SUP> weeks and within 3 days or randomisation. The method of induction was at the discretion of the attending physician and according to local protocol. Women with unfavourable cervix had cervical ripening with misoprostol or PGE2 followed by oxytocin infusion if labour had not started.</P>
<P>Comparison group: 413 women allocated to expectant management. Women were managed expectantly until labour started spontaneously or the woman required induction (depending on local policy), for example, if PROM occurred or the pregnancy continued beyond 41 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-11-26 12:36:43 +0000" MODIFIED_BY="[Empty name]">
<P>The primary outcome was a composite outcome: significant shoulder dystocia, fracture of the clavicle or long bone, brachial plexus injury, intracranial haemorrhage or death.</P>
<P>Significant shoulder dystocia was defined as difficulty with delivering the shoulders that was not resolved by the McRoberts&#8217; manoeuvre (flexion of the maternal thighs usually combined with suprapubic pressure) or requiring other manoeuvres (Woods, Rubin or Jaquemier) to rotate the fetus to displace the fetal shoulder impacted behind the maternal pubic bone. The definition also included a delay of 60s or more between delivery of the head and the body.</P>
<P>Secondary outcomes: mode of delivery, PPH (1000 mL or more), maternal blood transfusion, and anal sphincter tear, cord blood pH &lt; 7.10, Apgar score &lt; 7 at 5 minutes, admission to NICU, hyperbilirubinaemia (max value &gt; 350 mmol/L).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-11-26 12:36:45 +0000" MODIFIED_BY="[Empty name]">
<P>2 of the authors of this review (MB and OI) were investigators on this trial; these author were not involved in data extraction or in assessing risk of bias for this study. Independent data extraction was carried out by other members of the review team.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-29 08:55:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonen-1997">
<CHAR_METHODS MODIFIED="2016-02-29 08:55:27 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial carried out in Israel.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-29 08:54:36 +0000" MODIFIED_BY="[Empty name]">
<P>273 women with clinical or previous ultrasound suspicion of macrosomia, or with past history of macrosomia, underwent an ultrasound examination. Women were eligible if ultrasound estimated fetal weight, performed at 38 completed weeks or more, was between 4000 g and 4500 g. Women with diabetes, non-cephalic presentation, previous caesarean section, or indication for labour induction other than macrosomia were excluded. 6 women in the induction of labour group and 3 in the expectant management group refused to participate after randomisation. 2 women in the expectant management group were lost to follow-up.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Immediate induction of labour using either oxytocin or prostaglandins according to cervical status. Women in the expectant management group: labour was induced at 42 completed weeks of gestation unless fetal distress was suspected.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Caesarean section, instrumental delivery, and spontaneous delivery.<BR/>Mean birthweight, mean arterial cord blood pH, shoulder dystocia, cephalohematoma, clavicular fracture, brachial plexus palsy, intraventricular haemorrhage.<BR/>Some results are given stratified according to parity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information kindly provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-29 11:06:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-LIBBY-1998">
<CHAR_METHODS MODIFIED="2016-02-29 13:28:50 +0000" MODIFIED_BY="[Empty name]">
<P> Randomised controlled trial carried out in two centres in the UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-29 11:06:33 +0100" MODIFIED_BY="[Empty name]">
<P>59 women (30 induction; 29 await spontaneous labour) with a fetus estimated above the 97<SUP>th</SUP> percentile (abdominal circumference, estimated fetal weight according to <LINK REF="REF-Chitty-1994" TYPE="REFERENCE">Chitty 1994</LINK>).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Immediate induction of labour using either oxytocin or prostaglandins. Women in the expectant management group: labour was induced at 42 completed weeks of gestation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mode of delivery, birthweight, delay and adverse maternal or neonatal outcome.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No adverse fetal or maternal outcome. Standard deviation estimated from the information available (interquartile ranges).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-03-21 11:37:04 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Tey-1995">
<CHAR_METHODS MODIFIED="2016-02-29 08:53:44 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial carried out in the USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-11-26 12:40:03 +0000" MODIFIED_BY="[Empty name]">
<P>40 women at 37 to 42 weeks, with an ultrasound estimated fetal weight between 4000 g and 4750 g.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-03-21 11:37:04 +0000" MODIFIED_BY="Heather Maxwell">
<P>Induction of labour was performed with PGE<SUB>2</SUB> gel if the cervical status was unfavourable (Bishop score &lt; 6), followed by oxytocin infusion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean birthweight, caesarean section and shoulder dystocia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Additional information kindly provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>CPAP: continuous positive airways pressure<BR/>NICU: neonatal intensive care unit<BR/>PGE<SUB>2</SUB>: prostaglandins E<SUB>2</SUB>
<BR/>PPH: postpartum haemorrhage<BR/>PROM: premature rupture of membranes</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-11-23 11:46:35 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-03-21 11:35:05 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2016-03-21 11:35:05 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Perlitz-2014">
<CHAR_STUDY_NAME MODIFIED="2015-11-23 11:58:09 +0000" MODIFIED_BY="[Empty name]">
<P>Induction of labour versus expectant management of large for gestational age/macrosomic babies at term. A multi-center trial (IOLEMMT)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-11-23 11:58:46 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-03-21 11:35:05 +0000" MODIFIED_BY="Heather Maxwell">
<P>Women 18-45 years age with large for gestational age or suspected macrosomic babies 38 to 40 + 3 weeks' gestation with singleton pregnancy, cephalic presentation with estimated fetal weight 3800 to 4500 g. Women with diabetes, major fetal malformation or previous caesarean birth excluded. Proposed sample: 474 women.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-11-26 12:40:41 +0000" MODIFIED_BY="[Empty name]">
<P>Induction of labour versus expectant management (up to 40 weeks + 6 days).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-11-23 12:09:44 +0000" MODIFIED_BY="[Empty name]">
<P>Shoulder dystocia, brachial plexus injuries, fracture, intraventricular haemorrhage, cephalhematoma, caesarean section.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-11-23 12:03:30 +0000" MODIFIED_BY="[Empty name]">
<P>January 2015.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-11-23 12:07:37 +0000" MODIFIED_BY="[Empty name]">
<P>Dr Yuri Perlitz yperlitz@poria.health.gov.II</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-11-23 12:02:29 +0000" MODIFIED_BY="[Empty name]">
<P>Estimated completion 2019.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-03-21 11:08:07 +0000" MODIFIED_BY="Heather Maxwell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-02-29 08:50:33 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-29 08:50:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boulvain-2015">
<DESCRIPTION>
<P>Randomisation by centralised computer with permuted blocks (block size 4-8) with stratification by centre.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:47:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonen-1997">
<DESCRIPTION>
<P>Table of random numbers generated by computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:52:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-LIBBY-1998">
<DESCRIPTION>
<P>Table of random numbers generated by computer. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:57:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tey-1995">
<DESCRIPTION>
<P>Computer-generated table of random numbers. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-02-29 08:50:38 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-29 08:50:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boulvain-2015">
<DESCRIPTION>
<P>Central randomisation. Clinicians and participants had no access to the randomisation and women were randomised after consent had been obtained.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:48:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonen-1997">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:52:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-LIBBY-1998">
<DESCRIPTION>
<P>Sealed opaque, consecutively-numbered envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:57:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tey-1995">
<DESCRIPTION>
<P>Sealed opaque, consecutively-numbered envelopes, prepared by an individual not involved in the study. Envelopes were opened only after inclusion of women.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2015-11-17 15:08:17 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-07-28 11:06:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Boulvain-2015">
<DESCRIPTION>
<P>It was not feasible to blind women or clinical staff to treatment allocation and lack of blinding may have affected clinical management and outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-11-17 15:07:13 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gonen-1997">
<DESCRIPTION>
<P>It was not feasible to blind women or clinical staff to treatment allocation and lack of blinding may have affected clinical management and outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-11-17 15:08:00 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-LIBBY-1998">
<DESCRIPTION>
<P>It was not feasible to blind women or clinical staff to treatment allocation and lack of blinding may have affected clinical management and outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-11-17 15:08:17 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tey-1995">
<DESCRIPTION>
<P>It was not feasible to blind women or clinical staff to treatment allocation and lack of blinding may have affected clinical management and outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-11-23 11:45:17 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-17 15:53:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Boulvain-2015">
<DESCRIPTION>
<P>It was stated that the assessment of the primary outcome was by investigators masked to group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-11-23 11:44:02 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gonen-1997">
<DESCRIPTION>
<P>Not reported, likely that outcome assessment was not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-11-23 11:44:38 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-LIBBY-1998">
<DESCRIPTION>
<P>Not reported; it is likely that outcome assessment was not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-11-23 11:45:17 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tey-1995">
<DESCRIPTION>
<P>Not reported; it was likely that outcome assessment was not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-11-26 12:37:07 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-11-26 12:37:07 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Boulvain-2015">
<DESCRIPTION>
<P>There was very little attrition bias (822 women randomised 818 included in the analysis, 2 women in each group were lost to follow-up).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-04-08 11:49:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonen-1997">
<DESCRIPTION>
<P>All losses accounted for: 6 refused to participate in induction group and 3 in expectant group; 2 lost to follow-up from expectant group; this left 273 women available for analysis: 134 in induction group and 139 in the expectant group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-10-17 16:07:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-LIBBY-1998">
<DESCRIPTION>
<P>29/30 women in the induction group had induction, compared to 14/29 in the expectant management group; analysis was however performed on an intention-to-treat basis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-04-08 12:01:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tey-1995">
<DESCRIPTION>
<P>Not clear - only published as an abstract. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-03-21 11:08:07 +0000" MODIFIED_BY="Heather Maxwell" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-03-21 11:08:07 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Boulvain-2015">
<DESCRIPTION>
<P>The trial recruited between 2002 and 2009. It was first registered in 2005 which was at the point recruitment expanded from 1 to 2 countries and from 4 to 19 hospitals, so fairly early in the overall recruitment numbers. There is also a trial protocol available in French. Both registry and protocol planned sample size was 1000. Instead recruitment ended due to financial constraints in Jan 2009 before any analyses were conducted.</P>
<P>The published primary outcome &#8220;a composite of significant shoulder dystocia, fracture of the clavicle or a long bone, brachial plexus injury, intracranial haemorrhage, or death&#8221; includes two components &#8220;significant shoulder dystocia&#8221; and a delay of &gt; 60 seconds between delivery of the head and body, was not mentioned in the registry but was set out in the protocol.</P>
<P>For secondary outcomes, reduction of maternal morbidity and caesarean were mentioned in the registry and other secondary outcomes were pre-specified in the protocol. The fetal secondary outcomes, CPAP, phototherapy and hypoglycaemia and the maternal secondaries, sepsis, fever (&gt; 38.5 C) and retained placenta were not pre-specified in either the registry or the protocol.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:49:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonen-1997">
<DESCRIPTION>
<P>All expected outcome results reported. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 12:01:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-LIBBY-1998">
<DESCRIPTION>
<P>Not possible to tell - unpublished data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 12:01:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tey-1995">
<DESCRIPTION>
<P>Not clear - only published as an abstract.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-11-26 12:39:01 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-11-26 12:39:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Boulvain-2015">
<DESCRIPTION>
<P>Baseline characteristics were similar between groups (although maternal weight gain appeared greater in the expectant management group (15.6 kg versus 14.7 kg).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:50:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gonen-1997">
<DESCRIPTION>
<P>Baseline characteristics similar between groups. No other bias apparent. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 11:54:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-LIBBY-1998">
<DESCRIPTION>
<P>Unclear. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-08 12:01:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tey-1995">
<DESCRIPTION>
<P>Not clear - only published as an abstract.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-03-20 17:16:50 +0000" MODIFIED_BY="Heather Maxwell">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-03-20 17:16:50 +0000" MODIFIED_BY="Heather Maxwell" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-11-18 11:43:44 +0000" MODIFIED_BY="[Empty name]">Induction of labour versus expectant management for suspected fetal macrosomia</TITLE>
<TABLE COLS="6" ROWS="32">
<TR>
<TD ALIGN="LEFT" COLSPAN="6" ROWSPAN="1" VALIGN="TOP">
<P>Induction of labour versus expectant management for suspected fetal macrosomia</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="6" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: w</B>omen with term or near term (&gt; 37 weeks' gestation) with suspected fetal macrosomia<BR/>
<B>Setting: </B>data from four trials: a multi-centre study in France, Belgium and Switzerland and studies in UK, Israel and USA<BR/>
<B>Intervention: </B>induction of labour<BR/>
<B>Comparison: </B>expectant management</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with expectant management</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Induction</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Caesarean section</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.91<BR/>(0.76 to 1.09)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>1190<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>293 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>267 per 1000<BR/>(223 to 320)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>296 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>269 per 1000<BR/>(225 to 323)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Instrumental delivery</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.86<BR/>(0.65 to 1.13)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>1190<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1 2</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>152 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>130 per 1000<BR/>(99 to 171)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>148 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>127 per 1000<BR/>(96 to 167)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Shoulder dystocia</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.60<BR/>(0.37 to 0.98)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>1190<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1 3</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>68 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>41 per 1000<BR/>(25 to 67)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>61 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>36 per 1000<BR/>(22 to 59)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Brachial plexus injury</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.21<BR/>(0.01 to 4.28)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1190<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>4</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>3 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1 per 1000<BR/>(0 to 14)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Fracture (any)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.20<BR/>(0.05 to 0.79)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>1190<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH <SUP>5</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>20 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>4 per 1000<BR/>(1 to 16)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>10 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>2 per 1000<BR/>(0 to 8)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Low Apgar score (5 minutes)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.51<BR/>(0.25 to 9.02)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>858<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>4</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>5 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>7 per 1000<BR/>(1 to 42)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>2 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>4 per 1000<BR/>(1 to 22)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>Low arterial cord blood pH (&lt; 7.10)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.01<BR/>(0.46 to 2.22)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>818<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>2</SUP>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>29 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>29 per 1000<BR/>(13 to 65)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>29 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>29 per 1000<BR/>(13 to 65)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; <B>OR:</B> Odds ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Studies contributing data were at risk of bias (lack of blinding)</P>
<P>
<SUP>2</SUP> Wide 95% CI crossing the line of no effect</P>
<P>
<SUP>3</SUP> We downgraded this outcome for lack of blinding (clinical assessment of dystocia could be affected by lack of blinding)</P>
<P>
<SUP>4</SUP> Wide 95% CI crossing the line of no effect and low event rate</P>
<P>
<SUP>5</SUP> Not downgraded for low event rates due to fairly large sample, and 95% CI not crossing the line of no effect, and we considered this outcome was less likely to be affected by lack of blinding</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-03-21 11:09:20 +0000" MODIFIED_BY="Heather Maxwell">
<COMPARISON ID="CMP-001" MODIFIED="2016-03-21 11:09:20 +0000" MODIFIED_BY="Heather Maxwell" NO="1">
<NAME>Induction versus expectant management</NAME>
<DICH_OUTCOME CHI2="1.079301241851749" CI_END="1.0869820445151066" CI_START="0.7551943944069643" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9060257981088783" ESTIMABLE="YES" EVENTS_1="157" EVENTS_2="176" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.0362223701834291" LOG_CI_START="-0.12194124234234759" LOG_EFFECT_SIZE="-0.04285943607945924" METHOD="MH" MODIFIED="2015-12-02 10:22:41 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7820730761828427" P_Q="1.0" P_Z="0.28813196497206894" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" WEIGHT="100.0" Z="1.062228533756414">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0934121563656358" CI_START="0.7171895044788499" EFFECT_SIZE="0.8855414855414856" ESTIMABLE="YES" EVENTS_1="114" EVENTS_2="130" LOG_CI_END="0.038783897992677153" LOG_CI_START="-0.14436607463170714" LOG_EFFECT_SIZE="-0.05279108831951498" MODIFIED="2015-07-28 11:13:49 +0100" MODIFIED_BY="[Empty name]" ORDER="857" O_E="0.0" SE="0.10758320052654939" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.011574145035535739" WEIGHT="74.1128460308365"/>
<DICH_DATA CI_END="1.43624797328255" CI_START="0.5627231232578989" EFFECT_SIZE="0.8990049751243782" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="30" LOG_CI_END="0.15722942885538357" LOG_CI_START="-0.24970523857449756" LOG_EFFECT_SIZE="-0.046237904859557" MODIFIED="2015-12-02 10:22:34 +0000" MODIFIED_BY="[Empty name]" ORDER="2191" O_E="0.0" SE="0.23903543800740315" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" VAR="0.05713794062339107" WEIGHT="16.87222814427163"/>
<DICH_DATA CI_END="2.8258303261316935" CI_START="0.6251911204436003" EFFECT_SIZE="1.3291666666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.451146081561742" LOG_CI_START="-0.2039871988705918" LOG_EFFECT_SIZE="0.12357944134557508" MODIFIED="2015-12-02 10:22:41 +0000" MODIFIED_BY="[Empty name]" ORDER="2192" O_E="0.0" SE="0.3848285318879929" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" VAR="0.14809299895506794" WEIGHT="4.660883666467145"/>
<DICH_DATA CI_END="1.9540566763224334" CI_START="0.35165496883407854" EFFECT_SIZE="0.8289473684210527" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.2909371560343014" LOG_CI_START="-0.4538832416887207" LOG_EFFECT_SIZE="-0.08147304282720963" MODIFIED="2015-12-02 10:22:38 +0000" MODIFIED_BY="[Empty name]" ORDER="2193" O_E="0.0" SE="0.4375111885429338" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.1914160401002506" WEIGHT="4.354042158424725"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6419151168704338" CI_END="1.1342482654778487" CI_START="0.6472128275458672" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8567963743147574" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="91" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.05470812380406705" LOG_CI_START="-0.18895288373636032" LOG_EFFECT_SIZE="-0.06712237996614663" METHOD="MH" MODIFIED="2015-07-28 11:14:42 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7254540923446587" P_Q="1.0" P_Z="0.2802134662075768" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" WEIGHT="100.00000000000001" Z="1.079839967980373">
<NAME>Instrumental delivery</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.115355453125764" CI_START="0.576568915473766" EFFECT_SIZE="0.8019222430987137" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="68" LOG_CI_END="0.04741329494484936" LOG_CI_START="-0.2391487754096866" LOG_EFFECT_SIZE="-0.09586774023241862" MODIFIED="2015-07-28 11:14:42 +0100" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.16832797863138005" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.02833430839012634" WEIGHT="74.83473575185982"/>
<DICH_DATA CI_END="1.8192223221244894" CI_START="0.5275784651701247" EFFECT_SIZE="0.9796849087893864" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="18" LOG_CI_END="0.2598857762332892" LOG_CI_START="-0.2777129399047785" LOG_EFFECT_SIZE="-0.008913581835744686" ORDER="2194" O_E="0.0" SE="0.31578814701606445" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" VAR="0.09972215379583954" WEIGHT="19.541948644121046"/>
<DICH_DATA CI_END="3.3867744294732645" CI_START="0.3973101923440697" EFFECT_SIZE="1.16" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.529786272139955" LOG_CI_START="-0.4008702936861181" LOG_EFFECT_SIZE="0.06445798922691845" ORDER="2195" O_E="0.0" SE="0.546672273590534" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" VAR="0.2988505747126437" WEIGHT="5.6233156040191465"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2196" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.6540289160535" CI_END="0.9768214632739765" CI_START="0.36898877967071425" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.600363356384803" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="41" I2="24.642870772713014" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.010184806394210521" LOG_CI_START="-0.4329868398062024" LOG_EFFECT_SIZE="-0.22158582310020647" METHOD="MH" MODIFIED="2015-07-30 12:21:06 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.26526821685216007" P_Q="1.0" P_Z="0.03993791529744578" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" WEIGHT="100.00000000000001" Z="2.0543904638125148">
<NAME>Shoulder dystocia</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8606119272604773" CI_START="0.2603574600510326" EFFECT_SIZE="0.4733568796068796" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="32" LOG_CI_END="-0.06519263930445701" LOG_CI_START="-0.5844299739222941" LOG_EFFECT_SIZE="-0.32481130661337554" MODIFIED="2015-07-28 11:24:09 +0100" MODIFIED_BY="[Empty name]" ORDER="860" O_E="0.0" SE="0.30500258062077656" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.0930265741853333" WEIGHT="78.46395271867331">
<FOOTNOTE>Any shoulder dystocia</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="2.7653500074116253" CI_START="0.27021372496994417" EFFECT_SIZE="0.8644278606965174" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4417501073106813" LOG_CI_START="-0.5682925956273559" LOG_EFFECT_SIZE="-0.06327124415833736" ORDER="2205" O_E="0.0" SE="0.5933040834978182" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" VAR="0.35200973549518594" WEIGHT="14.513511463872648"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2206" O_E="0.0" SE="0.0" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.754728513460566" CI_START="0.37738446692572236" EFFECT_SIZE="1.4736842105263157" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7600248400618829" LOG_CI_START="-0.4232159792831024" LOG_EFFECT_SIZE="0.16840443038939024" ORDER="2207" O_E="0.0" SE="0.6950415144197628" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.4830827067669173" WEIGHT="7.022535817454051"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.2805210565965925" CI_START="0.010049672009244923" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.20740740740740737" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.6314966377587642" LOG_CI_START="-1.9978481120643379" LOG_EFFECT_SIZE="-0.683175737152787" METHOD="MH" MODIFIED="2015-07-30 12:21:09 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.308438237701513" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" WEIGHT="100.0" Z="1.0185045837151256">
<NAME>Brachial plexus injury</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-07-28 11:24:47 +0100" MODIFIED_BY="[Empty name]" ORDER="859" O_E="0.0" SE="0.0" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.280521056596591" CI_START="0.010049672009244923" EFFECT_SIZE="0.2074074074074074" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6314966377587641" LOG_CI_START="-1.9978481120643379" LOG_EFFECT_SIZE="-0.6831757371527869" ORDER="2208" O_E="0.0" SE="1.5444901215125124" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" VAR="2.3854497354497353" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2209" O_E="0.0" SE="0.0" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2210" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.22149457816806614" CI_END="0.7882652955341358" CI_START="0.052524741148223024" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.20347832956867423" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.1033275934292499" LOG_CI_START="-1.2796360792014079" LOG_EFFECT_SIZE="-0.6914818363153289" METHOD="MH" MODIFIED="2015-07-30 12:21:14 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.6379034944486088" P_Q="1.0" P_Z="0.021206221638305083" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" WEIGHT="100.0" Z="2.3042926435271385">
<NAME>Fracture (any)</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1816356646089976" CI_START="0.05393755452588227" EFFECT_SIZE="0.2524570024570025" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.07248359055468671" LOG_CI_START="-1.2681087479089133" LOG_EFFECT_SIZE="-0.5978125786771132" MODIFIED="2015-07-28 11:25:49 +0100" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.7874705756526187" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.6201099075186667" WEIGHT="64.30923592382581"/>
<DICH_DATA CI_END="2.119762244947608" CI_START="0.006263489631186213" EFFECT_SIZE="0.11522633744855967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3262871526751083" LOG_CI_START="-2.203183637187294" LOG_EFFECT_SIZE="-0.9384482422560929" ORDER="2211" O_E="0.0" SE="1.4858236630475226" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" VAR="2.2076719576719577" WEIGHT="35.6907640761742"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2212" O_E="0.0" SE="0.0" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2213" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="9.017633714328873" CI_START="0.25443962838930395" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5147420147420148" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="100.0" ID="CMP-001.06" LOG_CI_END="0.9550925907979566" LOG_CI_START="-0.5944152473848959" LOG_EFFECT_SIZE="0.18033867170653042" METHOD="MH" MODIFIED="2015-07-30 12:21:18 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.648232650698165" Q="3.7196125927112E-33" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="426" TOTAL_2="432" WEIGHT="100.0" Z="0.45621879780756774">
<NAME>Low Apgar score (5 minutes)</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant Management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.017633714328873" CI_START="0.25443962838930395" EFFECT_SIZE="1.5147420147420148" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9550925907979566" LOG_CI_START="-0.5944152473848959" LOG_EFFECT_SIZE="0.18033867170653042" MODIFIED="2015-07-28 11:21:08 +0100" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.9101885743361098" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.8284432408519999" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2204" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.221330041089168" CI_START="0.4590729835595217" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.00982800982801" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.3466130900095608" LOG_CI_START="-0.3381182647078624" LOG_EFFECT_SIZE="0.004247412650849203" METHOD="MH" MODIFIED="2015-11-26 12:41:38 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.9806009887244608" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="407" TOTAL_2="411" WEIGHT="100.0" Z="0.02431545091601576">
<NAME>Low arterial cord blood pH (&lt; 7.10)</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2213300410891677" CI_START="0.45907298355952175" EFFECT_SIZE="1.00982800982801" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.34661309000956075" LOG_CI_START="-0.3381182647078623" LOG_EFFECT_SIZE="0.004247412650849203" MODIFIED="2015-07-28 11:31:16 +0100" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.40221458723588494" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.1617765741853333" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.3128669224193334" CI_END="1.2031829552722766" CI_START="0.9915699422745033" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0922637289157768" ESTIMABLE="YES" EVENTS_1="356" EVENTS_2="332" I2="0.0" I2_Q="100.0" ID="CMP-001.08" LOG_CI_END="0.0803316709174238" LOG_CI_START="-0.003676646589747654" LOG_EFFECT_SIZE="0.03832751216383806" METHOD="MH" MODIFIED="2015-07-30 12:21:22 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.5100605639333404" P_Q="0.0" P_Z="0.07371032205414146" Q="7.908984198281995E-32" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" WEIGHT="100.00000000000001" Z="1.788407283641426">
<NAME>Spontaneous delivery</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours induction</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.288896557121144" CI_START="1.0055434507523624" EFFECT_SIZE="1.1384381808910111" ESTIMABLE="YES" EVENTS_1="239" EVENTS_2="212" LOG_CI_END="0.11021806361082022" LOG_CI_START="0.0024008417296506003" LOG_EFFECT_SIZE="0.05630945267023543" MODIFIED="2015-07-28 11:15:30 +0100" MODIFIED_BY="[Empty name]" ORDER="35" O_E="0.0" SE="0.06333236983685481" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.004010989069152156" WEIGHT="64.13860738103357"/>
<DICH_DATA CI_END="1.2267093544619594" CI_START="0.877159005943655" EFFECT_SIZE="1.037313432835821" ESTIMABLE="YES" EVENTS_1="91" EVENTS_2="91" LOG_CI_END="0.08874167706638461" LOG_CI_START="-0.05692167328780973" LOG_EFFECT_SIZE="0.01591000188928745" ORDER="2197" O_E="0.0" SE="0.0855633730432669" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" VAR="0.007321090806541253" WEIGHT="27.159770958887126"/>
<DICH_DATA CI_END="1.3270192786339101" CI_START="0.46486087294287054" EFFECT_SIZE="0.7854166666666667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.12287723224160797" LOG_CI_START="-0.3326770065811967" LOG_EFFECT_SIZE="-0.10489988716979437" ORDER="2198" O_E="0.0" SE="0.26759481491436626" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" VAR="0.07160698496905395" WEIGHT="4.946884667442128"/>
<DICH_DATA CI_END="1.7399023554470068" CI_START="0.7021121871437419" EFFECT_SIZE="1.105263157894737" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="13" LOG_CI_END="0.24052487605244355" LOG_CI_START="-0.15359348849026286" LOG_EFFECT_SIZE="0.043465693781090345" ORDER="2199" O_E="0.0" SE="0.23150707824975422" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.05359552727973782" WEIGHT="3.754736992637194"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1757131853603739E-31" CI_END="13.17452582430619" CI_START="1.0406452184645438" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.702702702702702" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="3" I2="100.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="1.1197349930995242" LOG_CI_START="0.017302693079299037" LOG_EFFECT_SIZE="0.5685188430894117" METHOD="MH" MODIFIED="2016-03-21 11:05:28 +0000" MODIFIED_BY="Heather Maxwell" NO="9" P_CHI2="0.0" P_Q="1.0" P_Z="0.04322934380053064" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="426" TOTAL_2="432" WEIGHT="100.0" Z="2.021487318481475">
<NAME>Third- and fourth-degree perineal tears</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="13.17452582430619" CI_START="1.0406452184645443" EFFECT_SIZE="3.7027027027027026" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="3" LOG_CI_END="1.1197349930995242" LOG_CI_START="0.01730269307929922" LOG_EFFECT_SIZE="0.5685188430894118" MODIFIED="2015-07-28 11:18:45 +0100" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.6475741901597768" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.4193523317610908" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2200" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-07-30 13:31:40 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="456" TOTAL_2="461" WEIGHT="0.0" Z="0.0">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-07-28 11:28:19 +0100" MODIFIED_BY="[Empty name]" ORDER="858" O_E="0.0" SE="0.0" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2218" O_E="0.0" SE="0.0" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2219" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.956135989859979" CI_START="0.1875149713376077" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0568181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.774964604958506" LOG_CI_START="-0.726964052150973" LOG_EFFECT_SIZE="0.024000276403766514" METHOD="MH" MODIFIED="2015-07-30 13:33:24 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.9500539486986219" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="470" TOTAL_2="463" WEIGHT="100.00000000000001" Z="0.06263903035303764">
<NAME>Intracranial haemorrhage</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-07-28 11:27:17 +0100" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.0" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.956135989859979" CI_START="0.1875149713376077" EFFECT_SIZE="1.0568181818181819" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.774964604958506" LOG_CI_START="-0.726964052150973" LOG_EFFECT_SIZE="0.024000276403766514" ORDER="2215" O_E="0.0" SE="0.8822403278528654" STUDY_ID="STD-Gonen-1997" TOTAL_1="44" TOTAL_2="31" VAR="0.7783479960899315" WEIGHT="100.00000000000001"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2216" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-07-30 13:33:27 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Convulsions</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2217" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2438447163062594" CI_START="0.3487028570324108" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6585834846704411" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.09476616567575126" LOG_CI_START="-0.45754449429787636" LOG_EFFECT_SIZE="-0.1813891643110625" METHOD="MH" MODIFIED="2015-07-30 13:33:27 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.19796265331939678" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="426" TOTAL_2="432" WEIGHT="100.0" Z="1.2873777567591267">
<NAME>Admission to neonatal intensive care unit</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2438447163062594" CI_START="0.3487028570324108" EFFECT_SIZE="0.6585834846704411" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="23" LOG_CI_END="0.09476616567575126" LOG_CI_START="-0.45754449429787636" LOG_EFFECT_SIZE="-0.1813891643110625" MODIFIED="2015-07-28 11:26:49 +0100" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.3244300156503688" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.10525483505489852" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2214" O_E="0.0" SE="0.0" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="27.6449576709477" CI_END="-40.80521674342015" CI_START="-315.2630423925518" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-178.03412956798599" ESTIMABLE="YES" I2="89.14811143605866" I2_Q="0.0" ID="CMP-001.14" MODIFIED="2016-02-29 09:12:42 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="4.311820818281298E-6" P_Q="1.0" P_Z="0.010998007396552203" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="16305.424172067529" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" UNITS="" WEIGHT="100.0" Z="2.5427621249049563">
<NAME>Mean birthweight (g)</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<CONT_DATA CI_END="-237.7348856724245" CI_START="-336.2651143275755" EFFECT_SIZE="-287.0" ESTIMABLE="YES" MEAN_1="3831.0" MEAN_2="4118.0" MODIFIED="2015-11-17 14:44:36 +0000" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="324.0" SD_2="392.0" SE="25.135724286860594" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" WEIGHT="28.94361074794955"/>
<CONT_DATA CI_END="7.688351260471535" CI_START="-147.68835126047153" EFFECT_SIZE="-70.0" ESTIMABLE="YES" MEAN_1="4062.8" MEAN_2="4132.8" ORDER="2201" SD_1="306.9" SD_2="347.4" SE="39.63764225938198" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" WEIGHT="27.42274630824043"/>
<CONT_DATA CI_END="-189.11112380806776" CI_START="-400.88887619193224" EFFECT_SIZE="-295.0" ESTIMABLE="YES" MEAN_1="3705.0" MEAN_2="4000.0" MODIFIED="2016-02-29 09:12:42 +0000" MODIFIED_BY="[Empty name]" ORDER="2202" SD_1="148.15" SD_2="251.85" SE="54.025929571752435" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" WEIGHT="25.500354457975412"/>
<CONT_DATA CI_END="200.0156127729661" CI_START="-206.0156127729661" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="4250.0" MEAN_2="4253.0" ORDER="2203" SD_1="317.0" SD_2="338.0" SE="103.58129760257196" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" WEIGHT="18.133288485834615"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="26.453571767413234" CI_END="-18.254979446859068" CI_START="-321.35801714308803" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-169.80649829497355" ESTIMABLE="YES" I2="88.6593764109558" I2_Q="0.0" ID="CMP-001.15" MODIFIED="2016-02-29 09:14:08 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="7.663692320747373E-6" P_Q="1.0" P_Z="0.02808840822542075" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="19261.294468162036" TOTALS="YES" TOTAL_1="590" TOTAL_2="600" UNITS="" WEIGHT="99.99999999999997" Z="2.1960493931608718">
<NAME>Sensitivity analysis: Mean birthweight (g)</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Expectant</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<CONT_DATA CI_END="-237.7348856724245" CI_START="-336.2651143275755" EFFECT_SIZE="-287.0" ESTIMABLE="YES" MEAN_1="3831.0" MEAN_2="4118.0" MODIFIED="2016-02-29 09:13:08 +0000" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="324.0" SD_2="392.0" SE="25.135724286860594" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" WEIGHT="30.055361655629092"/>
<CONT_DATA CI_END="7.688351260471535" CI_START="-147.68835126047153" EFFECT_SIZE="-70.0" ESTIMABLE="YES" MEAN_1="4062.8" MEAN_2="4132.8" MODIFIED="2016-02-29 09:13:08 +0000" MODIFIED_BY="[Empty name]" ORDER="2201" SD_1="306.9" SD_2="347.4" SE="39.63764225938198" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" WEIGHT="28.700160410703358"/>
<CONT_DATA CI_END="-111.16040756259767" CI_START="-478.8395924374023" EFFECT_SIZE="-295.0" ESTIMABLE="YES" MEAN_1="3705.0" MEAN_2="4000.0" MODIFIED="2016-02-29 09:13:59 +0000" MODIFIED_BY="[Empty name]" ORDER="2202" SD_1="324.0" SD_2="392.0" SE="93.79743397710651" STUDY_ID="STD-LIBBY-1998" TOTAL_1="30" TOTAL_2="29" WEIGHT="21.30827524582729"/>
<CONT_DATA CI_END="200.0156127729661" CI_START="-206.0156127729661" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="4250.0" MEAN_2="4253.0" MODIFIED="2016-02-29 09:13:08 +0000" MODIFIED_BY="[Empty name]" ORDER="2203" SD_1="317.0" SD_2="338.0" SE="103.58129760257196" STUDY_ID="STD-Tey-1995" TOTAL_1="19" TOTAL_2="21" WEIGHT="19.93620268784024"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.8533500407375183" CI_START="0.11669913987335502" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.31557125307125306" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="-0.0688727864440471" LOG_CI_START="-0.9329323448940665" LOG_EFFECT_SIZE="-0.5009025656690568" METHOD="MH" MODIFIED="2016-03-21 11:08:27 +0000" MODIFIED_BY="Heather Maxwell" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="0.023061451307019004" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="407" TOTAL_2="411" WEIGHT="100.0" Z="2.272415087302918">
<NAME>Non pre-specified outcome: significant shoulder dystocia</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8533500407375183" CI_START="0.11669913987335502" EFFECT_SIZE="0.31557125307125306" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="16" LOG_CI_END="-0.0688727864440471" LOG_CI_START="-0.9329323448940665" LOG_EFFECT_SIZE="-0.5009025656690568" MODIFIED="2015-11-17 14:52:19 +0000" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.5075528617973369" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.25760990751866664" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.7079375197865267" CI_START="0.1475026598921434" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.32314496314496316" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="-0.15000507000700855" LOG_CI_START="-0.8312001480514811" LOG_EFFECT_SIZE="-0.49060260902924485" METHOD="MH" MODIFIED="2016-03-21 11:08:46 +0000" MODIFIED_BY="Heather Maxwell" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="0.0047551920748010595" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="407" TOTAL_2="411" WEIGHT="100.0" Z="2.823166154338914">
<NAME>Non pre-specified outcome: serious neonatal morbidity or death (composite outcome)</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7079375197865267" CI_START="0.1475026598921434" EFFECT_SIZE="0.32314496314496316" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="25" LOG_CI_END="-0.15000507000700855" LOG_CI_START="-0.8312001480514811" LOG_EFFECT_SIZE="-0.49060260902924485" MODIFIED="2015-11-18 11:27:57 +0000" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.400137360813342" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.16010990751866666" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.658107259120639" CI_START="1.065662842458639" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.683046683046683" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.42457250147668407" LOG_CI_START="0.027619823057727033" LOG_EFFECT_SIZE="0.22609616226720552" METHOD="MH" MODIFIED="2016-03-21 11:09:04 +0000" MODIFIED_BY="Heather Maxwell" NO="18" P_CHI2="1.0" P_Q="1.0" P_Z="0.02556799885454728" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="407" TOTAL_2="411" WEIGHT="100.0" Z="2.232711147592972">
<NAME>Non pre-specified outcome: use of phototherapy</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6581072591206394" CI_START="1.0656628424586387" EFFECT_SIZE="1.683046683046683" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="27" LOG_CI_END="0.4245725014766841" LOG_CI_START="0.027619823057726943" LOG_EFFECT_SIZE="0.22609616226720552" MODIFIED="2015-11-18 11:37:07 +0000" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="0.23317196825074388" STUDY_ID="STD-Boulvain-2015" TOTAL_1="407" TOTAL_2="411" VAR="0.05436916677792591" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.127236522077203" CI_START="0.5295867322274608" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.074626865671642" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.9099428989478916" LOG_CI_START="-0.27606290384135446" LOG_EFFECT_SIZE="0.3169399975532686" METHOD="MH" MODIFIED="2016-03-21 11:09:20 +0000" MODIFIED_BY="Heather Maxwell" NO="19" P_CHI2="1.0" P_Q="1.0" P_Z="0.2948531576361345" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="134" TOTAL_2="139" WEIGHT="100.0" Z="1.0475344707482943">
<NAME>Non pre-specified outcome: cephalohematoma</NAME>
<GROUP_LABEL_1>Induction</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours induction</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expt management</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.127236522077203" CI_START="0.5295867322274609" EFFECT_SIZE="2.074626865671642" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.9099428989478916" LOG_CI_START="-0.27606290384135435" LOG_EFFECT_SIZE="0.3169399975532686" MODIFIED="2016-02-29 13:54:34 +0000" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="0.6966656793818102" STUDY_ID="STD-Gonen-1997" TOTAL_1="134" TOTAL_2="139" VAR="0.48534306882851924" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-03-21 11:08:08 +0000" MODIFIED_BY="Heather Maxwell">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-03-21 11:08:08 +0000" MODIFIED_BY="Heather Maxwell" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-03-21 11:08:08 +0000" MODIFIED_BY="Heather Maxwell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAATkAAAHNCAIAAADqgJupAAAVSklEQVR42u3dv45kSdHG4ZaQEMYY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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2015-06-17 14:55:04 +0100" MODIFIED_BY="[Empty name]"/>
<EXTENSIONS/>
</COCHRANE_REVIEW>